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Abstract 
In the 21 St Century, cancer becomes the second largest cause of death in people of 
various ages and racial backgrounds. Modern investigations have been focused on 
the use of immunotherapy to target and remove cancer cells by identifying substances 
like immunopotentiators and biological response modulators (BRM) that can prevent 
carcinogenesis and induce carcinostasis. Among various types of BRM, natural 
products like mushroom polysaccharides have become more and more popular and 
acceptable because they are natural and harmless to the hosts in general. In the 
present study, polysaccharides extracted from the sclerotium of Polyporus umbellatus 
were selected to evaluate their antitumor potentials both in vivo and in vitro. 
Immunomodulatory effect induced by the polysaccharides was also assessed by using 
ELISA and mouse cytokine array in the study. 
Two fractions, PU60a and PU60b, separated by ion exchange chromatography from 
60% ethanol-precipitated hot-water crude extract of P. umbellatus, were identified as 
p-glucans with heteroglycan chains. Fraction PU60a is regarded as a group of 
homogenous neutral polysaccharides while PU60b is a group of heterogenous acidic 
polysaccharides with various molecular weights ranged from 19.7 to 607.0 kDa. In 
the S-180 tumor model using BALB/c mice, PU60b exhibited the highest tumor 
inhibition ratio (89%) at a dose of 5 mg/kg (i.p). However, no remarkable 
proliferation inhibition of the cancer cell lines S-180, HL-60, HepG2, MCF-7 and 
Colon 201 was observed with all fractions isolated from hot-water crude extract 
(PUw). Hence, the possibility of direct cytotoxicity of PU60b on tumor cells was 
excluded. Other than that, fraction PU60b could inhibit tumor growth effectively in 
III 
BALB/c mice but mediated no tumor regression in athymic nude mice which are 
genetically defective in immune defense system in the body. It was implied that 
PU60b was not metabolized to tumor-sensitive toxic substances. Based on the result, 
the fraction PU60b most likely mediated tumor regression in vivo by the activation of 
host immune effector mechanism. 
In the assessment of TNF-a production using ELISA after administration of PU60b, 
the amount of TNF-a generated by LSP-primed mice on Day 10 was larger than that 
on Day 0; PU60b-treated mice on Day 10 with LPS stimulation generate a 3-fold 
increase in the production of TNF-a when compared with the control group. The 
results reflected that fraction PU60b exhibited immunostimulating effect which might 
last long in the hosts. Among 32 types of cytokines detected on membranes of 
mouse cytokine array (Ray Biotech), intensities of tissue inhibitor of matrix 
metalloproteinases-1 (TIMP-1) and macrophage inflammatory protein-2 (MIP-2) in 
PU60b-treated healthy mice serum were high. These studies could support that 
TIMP-1 and MIP-2 were probably involved in antitumor activity causing the 
production of a powerful cascade of chemokines and cytokines in the tumor mass and 








本課題研究的對象是屬多孔菌科的緒苍菌核 ( P o l y p o r u s umbellatus 
sclewtium).利用體外和體内抗癌作用實驗測試，對從豬等菌核中所提取的緒苳 
多糖作出評估。此外，本研究亦透過酵素連結免疫吸附分析（ELISA)以及鼠 
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1.1 General Introduction 
Cancer, in the 21®^  century, becomes the second largest cause of death in people of 
various ages and racial backgrounds, which has led to global scientific awareness and 
plenty of research studies in the fight against the disease. Recent investigations have 
been carried out on the development of immunotherapy to target and remove cancer 
cells as well as searching for substances like immunopotentiators and biological 
response modulators (BRM) that can prevent carcinogenesis and induce carcinostasis 
(Wasser, 1999). 
Since the 1960s，Japanese scientists have revealed that hot-water extracts from 
mushrooms belonging to the families of Phelinusceae, Tricholomataceae and 




against sarcoma 180 grafted on animals (Mizuno, 1995). Most medicinal mushrooms 
with effects against cancers of the stomach, esophagus and lungs belong to the family 
Polyporaceae (Mizuno, 1995; Daba and Ezeronye, 2003). The active substances that 
have antitumor potentials were isolated from these mushrooms afterwards and 
identified as polysaccharides. Among several healing properties, immunomodulatory 
and antitumor effects are regarded as their most promising biopharmacological 
activities (Ooi and Liu, 2000). The significant antitumor activity of mushroom 
polysaccharides is mainly due to their ability to activate the host immune system rather 
than direct cytotoxicity (Wasser, 2002). Lentinan, the first thoroughly investigated 
antitumor polysaccharide extracted from the fruiting body or mycelium oi Lentinus 
edodes in 1969 by Chihara and coworkers of the National Cancer Institute of Japan 
(Hobbs, 1995) is a classical example. Instead of attacking cancer cells directly, it 
serves as a host-defence potentiator, which restores and even enhances the 
responsiveness of host cells to lymphocytokines, hormone and other biologically 
active substances like cytokines (Hobbs, 2000). Injection of lentinan in mice 
produced either 80 % reduction in tumor size or complete regression of tumor in the 
test animals while treatment of immunosuppressive agents such as 
6-benzylthioguanosine or X-radiation with lentinan administration to mice showed 
reduction of its antitumor effect (cited by Hobbs, 1995). An intriguing conclusion 
has been drawn that an intact immune system with a functioning thymus gland is a 
requisite for the anticancer effect of lentinan (Maeda and Chihara, 1973; Dennert and 
Tucker, 1973; Yamada et al, 1981; cited by Hobbs, 1995). Another well-known 
antitumor p-glucan, schizophyllan isolated from Schizophyllum commune, is similar to 
lentinan in the biological activity and mechanism of antitumor action (Jong, 1991). It 




even enhance cellular immunity in the tumor-bearing host but it is ineffective in the 
mice that were neonatally thymectomized and treated with antithymus globulin 
(Suzuki, 1982; Isamu, 1984; cited by Ooi and Liu, 2000). 
Apart from antitumor activities, immunomodulation effects of mushroom 
polysaccharides also arouse people's attentions. Grifolan, p-D-glucans 
predominating Maitake, extracted from Grifola frondosa, enhances the activities of 
macrophages, nature killer (NK) cells and cytotoxic T cells by 1.4, 1.86 and 1.6 times 
respectively (Mori et al, 1987). Schizophyllan increases cellular immunity by 
restoring the activity of the suppressed killer-cell to normal level in mice with tumors 
(cited by Hobbs, 1995) and activates macrophages which lead to augmentation of T 
cell activities and increase sensitivity of cytotoxic LAK and NK cells to produce 
interleukin (IL) -2 (Shimizu et al” 1992). 
In the present investigation, Polyporus umbellatus, a famous Chinese medicinal 
mushroom in the family polyporaceae’ was selected to study its antitumor potentials 
both in vitro and in vivo. In the subsequent sections, more information on this 
medicinal mushroom together with the relevant literature reviews on this project will 
be given in detail. 
1.2 Cancer Treatment Modalities 
Cancer treatment modalities, up to now, can be categorized into local therapies and 
systemic therapies. Surgery and radiotherapy are examples of local therapies while 
chemotherapy is an example of systemic therapies. Depending on the type of cancer, 




treatment. Nevertheless, early tumor information is hardly detected for many forms 
of cancers and even small tumors may metastasize. Because of the undetectable 
metastasis, many modes of local therapies fail and in turn systemic therapies, 
chemotherapy, is widely used after localized treatment. Unfortunately, most of the 
chemotherapeutic agents developed in the past two decades are cytotoxins that are not 
specific only to cancer cells, but also to normal cells. In addition, those cytotoxic 
chemotherapeutic agents can cause self-limiting adverse reactions and even death in a 
host. Many chemotherapeutic agents are even carcinogenic, thus inducing secondary 
tumors due to immunosuppression (BoIk, 2001). 
1.3 Cancer Immunotherapy 
1.3.1 I mmuno modulation 
The major task of the immune system of a host is to defend against the attack of 
foreign pathogens. Immune surveillance, first proposed by Ehrlich in 1909，plays a 
critical role in preventing tumor development by searching out and destroying newly 
transformed cells (BoIk, 2001). Tumor cells recognized as transformed self-cells are 
present as foreign pathogens in the body, which may trigger actions of the immune 
system. It is believed that the nature of immune response is primarily determined by 
the nature of cytokine (Rincon et al, 1997). Cytokines are a group of 
low-molecular-weight regulatory proteins or glycoproteins secreted by leukocytes and 
a variety of other cells involved in the immune system; exerting a variety of effects on 
lymphocytes and other immune cells. Cytokine binds to specific receptor on the 
membrane of target cells, eliciting both biochemical and morphological changes 
responsible for signal transduction, which leads to transformed pattern of gene 




cytokines on activation and differentiation of T cells into Thl or Th2 subset (Schultze 
et al, 1999). Some of these cytokines exhibit cross-regulatory effect, on one hand 
enhancing their generation and a type of clone production and on the other hand 
suppressing production of other type of cytokines (Scott and Welt, 1997; Schultze et al, 
1999; Inoue et al.’ 2002). 
1.3.2 Conventional immunotherapy 
Conventional cancer immunotherapy is to either augment or supplement these natural 
defense actions. In general, this kind of treatment in human is more effective in 
patients with a relatively healthy immune system and a low tumor burden such as 
patient at an early stage of malignancy (Bolk, 2001). It can be classified into two 
overlapping categories: active and passive immunotherapy. 
1.3.2.1 Active immunotherapy 
Active immunotherapy refers to methods stimulating the host cellular or humoral 
antitumor immunity. This is often accomplished specifically by using tumor vaccines 
to generate an immune response to tumor-associated antigens, or by injection with 
non-tumor-specific antigens, such as microbial and fungal agents. 
1.3.2.2 Passive immunotherapy 
Passive immunotherapy refers to administration of agents like serum, immune cells 
from immunized animals and monoclonal antibodies together with cytokines that 
enable to increase immune activity in the host. Cytokines, IL-2 and tumor necrosis 
factor-alpha (TNF-a), are clinically used for cancer treatment. IL-2, a glycoprotein 




cells, especially CD4+ lymphocytes and CD8+ in small amounts (Goldsby, 2002). 
Various cytokines have been tested in combination with IL-2 to activate cytotoxic cells 
like lymphokine-activated killer cells (LAK) and also induce a lymphokine cascade 
with the induction of IFN-y, TNF-a, IL-1 and IL-6, which improves cytotoxic 
activities and clinical results in cancer patients (Bergmanna, 1994). Furthermore, the 
modulation of susceptibility of tumor cells through up-regulation of adhesion 
molecules, MHC class I/II antigens or tumor-associated antigens is also enhanced 
(Figure 1.1). TNF-a, released from macrophages and monocytes, is a growth factor 
for fibroblasts and is responsible for cachexia in cancer patients. In some instances, 
TNF-a may exhibit direct antitumor activity, killing some tumor cells, reducing the 
rate of proliferation of sparing normal cells as well as inhibiting tumor-induced 
angiogenesis by damaging the vascular endothelial cells in the vicinity of a tumor 
(Goldsby, 2002). In addition, TNF-a has a strong ability to increase the expression of 
epidermal growth factor receptor (EGFR) via the p55 TNF receptor (Schmiegel, 1997). 
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Figure 1.1 The significance of IL-2 on cellular interactions and immune 




On the other hands, passive immunotherapy with biological response modifiers (BRM) 
in Table 1.1 may be more successful. Any agents or approaches that enhance 
interactions between tumors and host via modification of host response to tumors are 
regarded as BRM. 
Table 1.1 Biological response modifiers can be categorized into different groups. 
Type of BRM Examples 
Effect cell Macrophages, NK cell, T cell clone, 
Tumor-infiltrating lymphocytes (TIL) 
Cytokine IL-1, IL-2, TNF-a, IFN-a, IFN-p, IFN-y 
Monoclonal antibody Monoclonal antibody to growth-promoting factor, 
Anti-T cell antibody, Anti-T suppressor cell antibody 
Natural product Lentinan, Schizophyllan and Krestin (PSK) 
Bacterial product Muramyl dipeptide, Endotoxin, Trehalase dimycolate 
Synthetic molecule Pyran copolymer, Malic anhydride-divinyl ether, 
Pyrimidine 
Hormone Thymosin, Thymulin, Thymopoietin 
(Wong, 1993; Hobbs, 1995; Goldsby, 2002) 
1.3.3 Novel immunotherapy 
The immune response of the tumor-bearing host towards the tumor involves 
complicating interactions among the effector cells, the cytokines and the 
corresponding secreted antibodies. Application of substances such as 
immunopotentiators and biological response modulators (BRM) to inhibit tumor 




effects to the host. 
1.3.3.1 Natural Products from Chinese Medicinal Herbs as BRMs 
Traditional Chinese medicine (TCM) is mainly applied based on the folklore or daily 
experience accumulated by Chinese people from generations to generations. Chinese 
medicine is more patient-oriented than disease-oriented. Instead of direct killing of 
cancer cells, TCM treatments usually restore the equilibrium in the human body, 
mobilizing the internal ability of the body to resist disease (Boik, 1996). This is 
difference from the idea of western medicine that puts emphasis mainly on etiology 
and the treatment of local condition. Other than that, toxic side effects mentioned 
above after chemotherapy in malignant tumors are one of the disadvantages of western 
medicine. 
Many Chinese traditional herbs like mushrooms were regarded as BRMs in cancer 
therapy. BRMs provide a different mode of action from the conventional 
chemotherapeutic agents because it is immunotherapeutic. Among the dominant 
immunologically active compounds, several high-molecular-weight glycoproteins, 
polysaccharides, nucleotides and proteins can be isolated from both edible and 
medicinal mushrooms. To evaluate the immuno-pharmacological potentials of 
mushroom bioactive substances, three levels of immunological tests should be applied 
(Leung, 1994): Lymphocytes count, lymphocyte morphology and determination of 
immunoglobulin level are included in the first level test; histochemical analysis of 
lymphoid organs, lymphocyte surface marker analysis and effector cells like NK and 
LAK cells medicated cytotoxicity are included in the second level; the measurement of 




namely IL-2, TNF-a and INF, phagocyte studies together with genetic analysis such as 
Northern blotting of specific mRNA are the third level study. 
1.4 Antitumor polysaccharides from Mushrooms 
1.4.1 Composition of mushroom antitumor polysaccharides 
Because of the high potential for structural variability that monosaccharides units in 
polysaccharide can interconnect at several points to form wide variety of branched or 
linear structures (Sharon and Lis, 1993), polysaccharides are a structurally diverse 
class of macromolecules which enable to offer the highest capacity for carrying 
biological information (Wasser, 2002) and provide the necessary flexibility to the 
precise regulatory mechanisms of various cell-cell interactions in higher organisms 
(Ooi and Liu, 2000; Daba and Ezeronye, 2003). Most of the clinical evidence stated 
that anti-tumor polysaccharides isolated from mushrooms like lentinan, krestin (PSK) 
and schizophyllan are mainly composed of p-(l—3)-linked D-glucans as the skeleton 
with various degree of branches substituted on the main chain through 
(1—6)-linkages. 
1.4.1.1 p-glucan 
A special group of p-(l—3)-linked polyglucose usually named "glucan" or "p-glucan" 
which produce D-glucose with acid hydrolysis (Kogan, 2000; Freimund, 2003). The 
main source of antitumor polysacchrides is related to cell walls which consist of 
polysaccharides like chitin, cellulose, p-(l—>3), (1—6)-glucans and a- (1—>3)-glucans 
or polysaccharide-protein complex. The homo- and hetero-glucans with p-(l—>3), 
p-(l->4) and p-(l->6) glucosidic linkages probably play a key role in some healthy 
properties of mushrooms such as enhancement of macrophage ftinction and host 
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resistance to bacterial, fungal, parasitic and viral infections, activation of non-specific 
immune stimulation, reduction of blood glucose and blood cholesterol levels (Cheung, 
1998; Manzi, 2000). Some mushroom antitumor polysaccharides which bind to 
protein residues are regarded as polysaccharide-protein complexes. 
1.4.1.2 Heteroglucan 
Besides the well-known antitumor p-(l->3)-glucan, a wide range of biologically 
active glucans with other composition have linear or branched molecules in a 
backbone with a - or p-linkage of glucose (Wasser, 2002). Heteroglucan contains side 
chains including glucuronic acid, xylose, galactose, mannose, arabinose or ribose in 
different combinations. Ganoderma lucidum contains various kinds of heteroglucans 
such as glucuronoglucan, xyloglucan, mannoglucan and xylomannoglucan (Mizuno, 
1999). 
1.4.1.3 Glycan and polysaccharide-protein complexes 
Many polysaccharides isolated from mushrooms are either homoglycans or 
heteroglycans. Glycans, in general, are polysaccharides containing units other than 
glucose in their backbone. Based on their individual sugar components in the 
backbone, they are classified as flicans, galactans, xylans and mannans. 
Heteroglycans contain side chains linked with arabinose, mannose, fucose, galactose, 
xylose and glucuronic acid and glucose in different combinations (Wasser, 2002). 
Polysaccharide-protein complexes are referred to polysaccharides bound to protein 
residues. PSK isolated from Coriolus versicolor is a typical example. It is a 
p-(l—4)glucan-protein complex with p-(l —>6)-glucopyranosidic side chains 
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including 25 - 38 % protein residues. The major constituent sugar is glucose with 
small amounts of mannose, fucose, xylose and galactose. The protein residues of 
PSK mainly composed of acidic amino acids such as aspartic acid and glutamic acid 
with small amounts of basic amino acids such as lysine and arginine (Ooi and Liu, 
2000). 
1.4.1.3.1 Immunomodulatory role of p-glucan 
The immunomodulatory activities ofp-glucans are still far from being understood up 
to now. Due to the use of p-glucans derived from various fungal sources with 
different MW and chemical modifications, the literature referring to the biological 
effects of p-glucans is inconsistent and often contradictory. In fact, 
immunomodulatory effects of P-glucans are also influenced by their degree of 
branching, polymer lengths and tertiary structure. Since the 1980s, Agaricus blazei 
was recognized to be an immune system stimulant. The immunostimulating 
polysaccharides extracted from this mushroom could promote the body's natural 
defense mechanisms to fight against diseases such as virus infection and cancer. 
Their main components was p-(l">6)-; p-(l-»3)-gIucan, acidic (3-(1^6)-; a 
.(l_>4)_glucan, and acidic a -(l->3)-glucan (Mizuno, 1990). Unlike the well-known 
p.(l_>3)-glucan, the antitumor polysaccharides of Agaricus blazei contain glucan 
with a (3-(l->6)-link:ed backbone. Another antitumor polysaccharide of Agaricus 
blazei’ HM3-G is a proteoglucan with mainly glucose (> 90 %) which mediated 
activation of natural killer cells (Wasser, 2002). 
Studies on large MW or particulate p-glucans like zymosan demonstrated that they 
may directly activate leukocytes, stimulating their phagocytic, cytotoxic and 
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antimicrobial activities in vitro. These carbohydrates stimulate the production of 
cytokines and chemokines namely IL-lp, IL-6, IL-8 and TNF-a (Brown, 2003). In 
addition, stimulation of p-glucans with large MW also enhances the activities of 
macrophages to recognize and clear apoptotic cells via up-regulation of the PS 
receptors. On the contrary, intermediate or low MW p-glucans such as glucan 
phosphate has less cellular effects in vitro, but exhibit biological activities in vivo. A 
classical example is Lentinan [400 - 800 kDa (MW)] which can stimulates activities 
of macrophages, NK-cells, T and B lymphocytes. Its primary structures comprise a 
p-(l->3)-glucan including five p-(l-»3)-glucose residues in a linear linkage and two 
p-( 1 -»6)-gIucopyranoside branches in side chains which form a right-handed triple 
helical structure (Ooi and Liu, 2000). 
1.4.1.3.2 Structure-Activity Relationship of p-glucan 
A critical factor contributing to the characteristics of the antitumor and 
immunomodulatory effects of p-glucans is their ultrastructure (Yadomae, 1996; 
Wasser, 2002). Though it is difficult to correlate the structure and antitumor activity 
of complex polysaccharides, their relationships can be inferred. The above quoted 
examples showed that structural features such as p-(l-^3) linkages in the main chain 
and p-(1^6)- branched chain are needed for antitumor action, p-glucans containing 
mainly (l->6)-linkages in the main chain have less activity. It is known that soluble 
p-(l->3)-D-glucan may exist in three kinds of conformers: the single helix, triple helix 
and random coil (Ohno, 1987a and b; Ooi and Liu, 2000). Ohno (1995) believed that 
the antitumor activity of p-glucans obviously depends on the helical conformation. A 
triple-helical tertiary conformation of p-(l->3)-glucan is important for their 
immunostimulating activity (Wasser, 2002). Schizophyllan in form of triple helix 
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Structure exhibits pronounced antitumor activity while schizphyllan - O H in form of a 
single helix structure derived from the alkaline-treated schizophyllan diminishes its 
ability to inhibit tumor growth (Chihara, 1992). The same results which verify the 
correlation between antitumor activity and triple helix structure were obtained upon 
the investigation of lentinan (Maeda, 1988). 
1.4.2 Antitumor polysaccharides from Polyporaceae mushrooms 
In 1968, notable host-mediated antitumor potential of mushrooms against cancer like 
sarcoma 180 was discovered by Ikegawa et al. He claimed that most of the antitumor 
mushrooms mainly belong to the families of Polyporaceae and Tricholomataceae 
Table 1.2). In the following parts, the polysaccharides extracted from Lentinus 
edodes, Grifola frondosa and Ganoderma lucidum are selected to introduce their 
promising immunomodulatory and antitumor effects in detail. 
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Table 1.2 Antitumor Effects of mushroom water extracts on sarcoma 180 bearing 
mice 
Scientific Name Family Polysaccharides Tumor inhibition 
obtained (%) 
Coriolus versicolor Polyporaceae p-Glucan; 77.5 
p-Glucan-protein 
Coriolus hirsutus Polyporaceae - 65.0 
Coriolus pubesscens Polyporaceae - 59.5 
Daedaleopsis tricolor Polyporaceae - 70.2 
Favolus alveolarius Polyporaceae - 71.9 
Ganoderma Polyporaceae P-Glucan 64.9 
applanatum 
Ganoderma lucidum Polyporaceae p-Glucan; -
Hetero-p-glucan 
Ganoderma tsugae Polyporaceae - 77.8 
Grifola frondosa Polyporaceae p-Glucan; 86.6 
Acidic p-Glucan 
Trametes dickinsii Polyporaceae - 80.1 
Trametes gibbosa Polyporaceae - 49.2 
Lentinus edodes Tricholomataceae p-Glucan 80.7 
Flammulina velutipes Tricholomataceae p-GIucan-protein 81.1 
Pleurotus ostreatus Tricholomataceae p-Glucan 75.3 
Tricholoma matsutake Tricholomataceae - 91.8 
(Mizuno et al” 1995;Hobbs, 1 9 9 5 ) ~ 
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1.4.2.1 Lentinan from Lentinus edodes 
Lentinan, produced from Lentinus edodes, is a p-(l—>3), (1—6)-D-glucan with 
effective antitumor and immunopotentiating activity. A right-handed triple helical 
structure of lentinan is formed by its primary structure, p-(l—>-3)-D-glucan consisting 
of five p-(l—>3)-glucose residues in a linear linkage and two 
P-(l—6)-glucopyranoside branches in side chains (Ooi and Liu, 2000). The prepared 
glucan are usually heterogeneous and lentinan has particularly large MW ranging from 
400 to 1000 kDa. Its oral bioavailability is reportedly limited; thus, it has been 
routinely administered intravenously. Lentinan, indicated by Open-label clinical 
studies, may prolong life in cancer patients especially those with gastric or colorectal 
carcinomas (Fume, et al, 1981). Tumor responses and prolonged median survival 
time of patients with recurrent gastric cancer were also noted (Daba and Ezeronye, 
2003). Lentinan has been satisfactorily proven to potentiate human immunity 
(Wasser, 1999). The most intriguing aspect of lentinan use in conjunction with other 
chemotherapeutic agents such as cyclophosphamide is its apparent ability to greatly 
reduce the debilitating effects of the chemotherapy such as nausea, pain, hair loss and 
lowered immune status. 
Lentinan does not attack cancer cells directly, but exhibits the anti-tumor effect by 
activating various immune responses in the host. It can stimulate peripheral blood 
lymphocytes to increased lymphokine-activated killer (LAK) cell and natural killer 
activity mediated by interkeukin 2 both in vitro and in vivo (Arinaga, et al.’ 1992; 
Fujimoto, et al., 1992 and Tani, et al.，1993). Other than these, lentinan can also 
inhibit both prostaglandin synthesis, which decelerates T-cell differentiation in 
animals and humans (Aoki, 1984)，and suppressor T-cell activity in vivo. In addition, 
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lentinan enables to increase the ratio of activated T helper cells and cytotoxic T cell in 
the spleens of gastric cancer patients with chemotherapy (Hobbs, 2000). Miyakoshi 
and Aoki (1984) revealed that lentinan enables to stimulate Ig production in human 
cells in vitro and increase level of interferon in the peripheral blood circulation of 
cancer patients. 
1.4.2.2 Maitake from Grifola frondosa 
Maitake, p-D-glucan isolated from Grifola frondosa, was reported to have strong 
antitumor activity in xenographs (Kurashiga, et al.’ 1997). Crude maitake powder 
and Maitake D-fraction have demonstrated their considerable inhibition of hepatic 
metastasis in a series of experiment using a mouse model: 81 % inhibition was 
observed by crude Maitake powder while 91 % inhibition was performed by 
D-fraction (Nanba, 1995). In 1997，Nanba discovered that significant symptomatic 
improvement or tumor regression in 11 out of 15 hepatocellular carcinomas with 
D-fraction plus Maitake. Combination of D-fraction plus Maitake with 
chemotherapy made the overall response rates increased by 12 to 28 %• 
Another highly purified polysaccharide from Grifola frondosa, p-glucan (Grifron-D, 
GD) that is a p-(l-> 6) glucan branched with a P-(l->3) linkage has also been revealed 
to have remarkable immunomodulatory and antitumor effects on animal models 
(Nishida et al, 1988; Daba and Ezeronye, 2003). Fullerton, et al (2000) observed 
the cytotoxic effect of GD on human prostate cancer cells (PC 9) in vitro. He implied 
that oxidative stress is a possible action causing 95 % cell death in apoptosis. The 
Food and Drug Administration has approved Grifon-D for clinical trials under an 
investigational New Drug Application (IND) for patients with advanced cancer 




1.4.2.3 Polysaccharides from Ganoderma lucidum 
Ganoderma lucidum and other related Ganoderma species have been used extensively 
as "mushroom of immortality" in China and other Asian countries for thousands of 
years (Hobbs, 1995). However, pure p-glucan product derived from this particular 
mushroom has not been commercially available until now. It is because 
polysaccharides extracted from the mycelium and fruiting body of Ganoderma species 
such as G. applanatum, G lucidum and G. tsugae showed promising antitumor and 
immunostimulating activities with qualitative and quantitative difference in the 
average molecular weight, sugar composition and protein contents. 
A p-D-glucan called G-1 (Mizuno et al” 1982; Wasser and Weis, 1999; Gao and Zhou, 
2002) exhibits potent action against sarcoma 180 (Willard, 1990) while a 
polysaccharide-rich fraction of G. lucidum has demonstrated to be a 
polysaccharide-protein complex with the ability to perform mitogenicity and stimulate 
immune effector cells like macrophages, NK and T cells to generate more tumor 
necrosis factor (TNF-a) and a number of interleukins (Gao and Zhou, 2002). The 
sugar portion of the protein bound polysaccharides contains glucose, galactose, 
mannose, and traces of xylose and flicose while the protein portion is composed of 17 
amino acids (Hobbs, 1995). 
There is evidence that the P-D-glucans induce a biological response by binding to 
membrane complement receptor type 3 (CR3) consisting of the otm (CD l ib) and P2 
(CD 18) chains on immune effector cells such as macrophages (Battle et al, 1998; 
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Mueller et al.’ 2000; Brown, 2003). The p-D-glucan binding site, a lectin domain of 
CR3, maps to a site C-terminal to the I-domain (Muller et al” 1996) and its distinct 
metal ion dependent adhesion site for the many protein ligands of CR3 like iC3b, 
ICAM-1 and fibrinogen (Diamond et al, 1993; Thornton et al, 1996). The 
ligand-receptor complex can be internalized (Muller et al,’ 1996). Though the 
intercellular events occurring after glucan receptor binding have not been fully 
understood, it is believed that p-D-glucan can help override the resistance of 
iC3b-opsonized tumor cells to the cytotoxic activation of phagocyte and NK cell CR3, 
allowing the effector mechanism of the complement system to function against tumor 
cells (Xia et al., 1999). 
1.4.3 Extraction and purification of Polysaccharides from Mushrooms 
There is consideration in deciding methods of polysaccharide extraction. As briefly 
mentioned in section 2.3.1.1.1, antitumor and immunnomodulatory effects of 
P-glucans are definitely affected by many factors such as their chemical composition, 
solubility in water, size of molecules, degrees and modes of branching together with 
binding modes of p-(l->6) to the main sugar chain of 3) (Mizuno, et al, 1995; 
Ooi and Liu, 2000). Some findings on this issue stated that the conformation of 
glucans used for determining biological activities is strongly dependent on the 
extraction and purification procedures (Yadomae and Ohno, 1996). 
Based on various principles for isolating and purifying polysaccharides from 
mushrooms, a list of method is summarized as below (Wong, 1993): (1) Solubilty: i) 
fractional precipitation, ii) fractional solution, iii) distribution between immiscible 
solvents; (2) Ultracentrifugation: i) density gradient techniques; (3) Memebrane 
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ultrafiltration; (4) Chromatography: i) adsorption, ii) ion-exchange, iii) partition 
chromatography; (5) Gel filtration. 
1.4.4 Chemical modification 
Many studies demonstrated that chemical modification of mushroom polysaccharides 
is a possible technique to improve their antitumor activity. Water-insoluble p-glucans 
extracted from Cordyceps ophioglossoides and Aurilcularia auricula are relevant 
examples which can be converted into water soluble ones by carboxymethylation, 
hydroxyethylation and Smith degradation etc. so that their biological activities become 
higher (Mizuno, 1995). Some mushroom polysaccharides like Pachyman of p-glucan 
isolated from sclerotium of Poria cocos fail to show antitiumor activity originally. 
After Smith degradation, treatment of urea and hydroxyethylation, pachyman was 
respectively converted into pachymaran, U-pachyman and hydroxyethylpachyman 
exhibiting strong antitumor activity (Chihara, 1970). 
1.5 Polyporus umbellatus (Zhuling) 
Polyporus umbellatus is a well-known Chinese medicinal Basidiomyceta fungus 
belonging to the order Polyporales，and family Polyporaceae (Hu, 2001). This 
mushroom is also referred to as Grifola umbellata (Pers.: Fries) or polyporus 
sclerotium. Sometimes it is named as Zhu ling in China and Choreimaitake in Japan 
(Stamets, 1993; Hobbs, 1995). It is mainly found in the temperate regions of China 
like Fu Jian, Si Chun, and Yun Nan provinces but infrequently occur throughout the 
deciduous woodlands of northeastern North America (Hu, 2001; Hobbs, 1995). Its 
grayish white circular fruiting body with central stems arising from underground is a 
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gourmet mushroom known as "Hog Tuber Flowers" while its sclerotium elongating 
lumps with tuberous or branched ginger-like structures is a Chinese medicinal herb 
that has been reported in China to have anti-tumor and immunodulatory effect (Hu, 
2001; Ooi, 2001; Zhang, 2001). One thing should be reminded that the similar 
appearance of P. umbellatus and Grifola fwndosa readily confuses amateur collectors. 
Grifola frondosa, macro scop ically appears to be a close relative to P. umbellatus, but 
the two mushrooms have biologically unique life cycle. Grifola fwndosa lacks the 
sclerotial stage in its life cycle and arises from a multiple forking base. 
1.5.1.1 Nutritional Contents 
The sclerotia of P. umbellatus with its woody texture have substantially more 
polysaccharides and less protein than the fleshy fruitbody. According to Hu (2001), 
80 % of the whole nutrient components of P. umbellatus sclerotia is polysaccharide. 
Other nutrients isolated from this mushroom are proteins, ergosterol, 
a-hydroxy-tetracosanoic acid, and biotin. Its mineral contents (ppm) like calcium 
(23,400), iron (1,800), potassium (1,010) and sodium (103) were also measured by 
Suzuki et al. (1982). An interesting finding by Guo et al. (1992) was that 2-year-old P. 
umbellatus contains polysaccharides and ergosterol much more that those of 1 and 
3-year-old P. umbellatus. 
1.5.1.2 Medicinal properties 
P- umbellatus (Zhuling) used in traditional medicine is considered to have a sweet and 
bland taste (Bensky and Gamble, 1993). Zhuling primarily serves as a diuretic; 
meanwhile, it also acts as a drug exhibiting liver protection, antitumor and 
immunostimulating effects (Hu, 2001; Zhang, 2001). 
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1.5.1.2.1 Diuretic effect 
Diuretic effect is the most important use of Zhuling in TCM. It serves as a diuretic for 
promoting urination and leaving out dampness. Some problems arose by stagnance of 
dampness such as edema, scanty urine, painful urination and urinary tract infections, 
diarrhea, jaundice together with leucorrhea were treated by Zhuling (Yuan et al, 2004; 
Bensky and Gamble, 1993; Chang and But, 1986). The mechanism of this property is 
that Zhu ling increases urine output and elevates excretion of sodium and chloride by 
inhibiting active transport of chloride and blocking sodium reabsorption in the 
ascending loop ofHelene (Huang et al., 1985). 
1.5.1.2.2 Antitumor and immunomodulatory activity 
Zhu ling has been announced to possess potent anticancer and immunopotentiating 
properties in China for long time. However few scientific studies have been 
conducted. According to the limited studies in the 1980s, not only crude and refined 
hot-water extracts of Zhu ling (Miyazaki, 1979，Ueno，et al 1982, Chang and But, 
1986 and Ying, et al.’ 1987), but also its ethanolic extract demonstrated remarkable 
antitumor effects against sarcoma 180，hepatoma and other types of 
experimentally-induced cancers in a number of in vitro and in vivo studies. It is 
believed that the extracts enable to promote the Ig M production and strengthen the 
phagocytic power of monocytes (Chang and But, 1986); moreover, it improves 
cellular immunity such as macrophage proliferation and activity in normal and 
liver-compromised mice (Zhang et al” 1991). 
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1.6 The Objective of the Present Project 
In the present investigation, Polyporus umbellatus under the family Polyporaceae, 
was selected to study its antitumor potentials both in vitro and in vivo. The sclerotium 
of the mushroom possesses medicinal properties figured prominently in Chinese 
pharmacopeia. Numerous Chinese physicians administer extracts of sclerotia of 
Polyporus umbellatus in the treatment of lung cancer, cervix cancer, liver cancer 
leukemia and cancer of mammary glands (Bo and Yun, 1980). Nevertheless, the 
quality of the pharmalogical studies and instrumentation in China is much variable and 
their protocols are not as systematic as western ones accepted for scientific testing and 
evaluation. Hence, clarification of both in vitro and in vivo antitumor effects of 
extracts, especially its polysaccharides components, from sclerotia of Polyporus 
umbellatus is necessary. 
Apart from this, polysaccharides of Polyporus umbellatus were noted to provide 
nonspecific immunostimulant or immunopotentiating action (Chang and But, 1986). 
A courageous hypothesis is made that immunomodulatory effects induced by 
Polyporus umbellatus polysaccharides may have correlation to tumor regression. To 
verify this hypothesis, enzyme-linked immunosorbent assay (ELISA) and mouse 
cytokine array were conducted to determine the effects of cytokines and T cells 
productions in animal models. The flow chart illustrating the investigation of 
immunopharmacological and antitumor activities of polysaccharides extracted from 
Polyporus umbellatus sclerotia (Figure 1.2). 
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(1) Hot-water/ alkaline extraction 
(2) Ethanol precipitation 
(3) DEAE gel filtration 
J r   
Antitumor activity in vitro and in vivo 
I I 
• I i I  
In vitro - In vitro + In vitro - In vitro + 
In vivo - In vivo - In vivo + In vivo + 
1 r 
Direct cytotoxic ^  
effect on tumor 
cells ^ r  
Immunotoxicological  
studies 
^ r  
Immunostimulating studies 
• Athymic nudemice model 
• ELISA 
• Mouse cytokine array 
y r  
Host-mediated antitumor activities 
Figure 1.2 A flow chart of the investigation of immunopharmacological and 
antitumor activities of polysaccharides of Zhuling. 
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2.1 Extraction 
2.1.1 Hot-water extraction of crude Polyporus umbellatus polysaccharides 
Dried sclerotium of Polyporus umbellatus (Figure 2.1) was purchased from a Guang 
Zhou herbal dealer. The sample was washed and ground into small pieces with a 
blender before boiling three times in distilled water [sample: distilled water (w/v) = 1 ： 
7] for two hours each time (Figure 2.2). After each sample boiling, the residue and 
the insoluble components in the water extract were isolated by filtration with gauze 
and centrifugation at 15,600 g for 30 minutes with the aid of Beckman J2-MI 
centrifuge and a JA-14 rotor. The clear supernatants of each crude sample extract 
were pooled and then concentrated by a rotary evaporator (BUCHI Rotavapor R-200). 
Absolute ethanol was gently added into the part of the concentrated hot-water crude 
extract until 80 % aqueous ethanol concentration with stirring overnight at 4 � C , 
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allowing precipitation of the polysaccharide (PU80). Meanwhile, absolute ethanol 
was added gently into the other portion of the concentrated hot-water crude extract 
until 60 % aqueous ethanol concentration with stirring overnight at 4 °C in order to 
obtain the relatively higher molecular weight polysaccharides (PU60). Both 
precipitates were collected by centrifligation (15,600 g, 30 min). The pellets were 
re-dissolved into distilled water and were placed into dialysis tubing (Spectra/Por®, 
MWCO: 6 一 8,000) for dialysis against distilled water at 4 °C for two days. The two 
pale brown freeze-dried products collected from the 60 % and 80 % ethanol 
precipitation were regarded as PU60 and PU 80，respectively. 
2.1.2 Cold-alkaline extraction of crude Polyporus umbellatus polysaccharides 
The residue remained after the hot-water extraction was soaked with 1 M sodium 
hydroxide solution [sample: sodium hydroxide solution (w/v) = 1:7] with stirring 
overnight at 4 °C. The cold alkaline crude extract was collected by centrifligation 
(15,600 g, 30 min) and neutralized with 1 M hydrochloric acid. The salt formed in the 
mixture was removed by centrifligation and the supernatant was dialyzed. The 
alkaline-soluble crude polysaccharides were obtained by 80 % ethanol precipitation. 
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Figure 2.1 a) Sclerotium of Polyporus umbellatus in the wild environment. (Hu, 2001) 
b) Dried sclerotium of Polyporus umbellatus purchased from Guang Zhou. 
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Dried scelerotium of Polyporus umbellatus (700 g) 
i 
Washed and ground with a blender 
i 
_ ^ Boiled with distilled water (v/v =1:7) for 2 hours each time 
Repeated extraction Removed the residue by centrifugation 
( ) ( 1 5 , 6 0 0 g, 30 min) 
Residue Supernatant 
i 
Added absolute ethanol into the supernatant with stirring (4 °C, overnight) 
to achieve a final aqueous ethanol concentration of 60 % or 80% 
i 
Collected precipitates by centrifugation (15,600 g’ 30 min) 
i 
Re-dissolved in distilled water 
i 





Fractionated PU60 with DEAE-column 
i 
Eluted with distilled water • • [ = = = > mm 
Eluted with 0.15 MNaCl • 丨 > f & M 
Figure 2.2 Flow chart illustrating the extraction and fractionation of Polyporus 
umbellatus polysaccharides. 
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2.2 Purification of crude Polyporus umbellatus polysaccharides 
2.2.1 Preparation of DEAE-cellulose ion exchange column 
Dried form of DEAE-cellulose resin (Sigma, USA) was soaked in distilled water 
overnight at 4 °C. The swollen resin was treated in double volumes of 0.4 N 
hydrochloric acid for 30 minutes. After discarding the hydrochloric acid solution, the 
acidic resin was washed with distilled water until its pH value was near 7.0. The resin 
was further soaked in double volumes of 0.4 N sodium hydroxide solution for 30 
minutes. The sodium hydroxide solution was discarded and the alkaline resin was 
washed with distilled water again until its pH value was neutral. The prepared resin 
was degassed and packed into a vertical column (2.5 cm x 30 cm). 
2.2.2 Fractionation of hot-water soluble crude polysaccharide (PU) 
Crude PU60 polysaccharides were fractionated by anion exchange chromatography. 
Eighty milligrams of the freeze-dried PU60 was completely dissolved into distilled 
water, loaded onto the distilled-water equilibrated DEAE-cellulose anion exchange 
column (2.5 cm x 30 cm) and eluted at a flow rate of 30 ml/h. The fractions were 
collected at 6 ml/tube. The unbound polysaccharide eluted by washing the column 
with distilled water was firstly collected, designated as PU60a. The retained 
components were then eluted with a linear gradient of sodium chloride solution ranged 
from 0 to 1.0 M at a flow rate of 30ml/h. Carbohydrate content on each tube was 
assayed by the phenol-sulfuric method (Dubois et al, 1956). According to the elution 
profile of PU fraction on DEAE cellulose column shown in the result section, majority 
of the retained polysaccharides was eluted by washing the column with 0.15 M sodium 
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chloride solution. The retained component then was collected, which was designated 
as PU60b. PU60b was dialyzed against distilled water at 4 °C to remove the salt 
before lyophilizing. 
2.3 Characterization of Polyporus umbellatus Polysaccharides 
2.3.1 Carbohydrate content determination 
The amounts of polysaccharides in the all fractions of PU were determined by the 
phenol-sulfliric assay (Dubois et al” 1956; Shouji et al., 2000), which is a simple but 
universal biochemical assay for estimating the carbohydrate content. The principle of 
this method is that mixing sugar samples with phenol and concentrated sulfuric acid 
forms yellowish brown products with color intensity directly proportional to the 
quantity of carbohydrate content. Compared with a calibration curve made from 
sugar standard, the approximate amount of carbohydrate in the PU fractions could be 
determined. 
Before the experiment, freeze-dried PU fractions were dissolved into distilled water. 
Aliquots of the samples (200 |al) were mixed with equal volume of 5 % phenol in 
distilled water and stood at room temperature for 10 minutes. Concentrated sulfuric 
acid (98.8 %, 1 ml) was rapidly squeezed to the surface of liquid and the mixtures were 
mixed well with a vortex-mixer and left undisturbed for 30 minutes for color 
development. The absorbance was measured by a spectrophotometer (Milton Roy 
Spectronic 3000) at a wavelength of 490 nm. Blank and standard curve, using 
distilled water and D-glucose ranged from 0 - 800 ^ig/ml respectively, were treated by 
the same procedures. The carbohydrate content in the PU fractions can be calculated 
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by the following equation derived from the glucose standard curve: 
. , , , , � Average absorbance at 450 nm of sample + 0.014 Glucose content m sample (/ig/ml) = ^ 謝 
2.3.2 Gas chromatography (GC) 
Gas chromatography (GC) is commonly used to determine the composition of neutral 
monosaccharides like glucose, mannose, and galactose in sugar samples. In this 
study, fifteen milligrams of all the PU fractions were hydrolyzed with 0.7 ml of 12 M 
sulfuric acid at 35 °C for 1 hour with frequent gently shaking. The hydrolysates 
were then diluted to 2 M sulfuric acid with 3.5 ml distilled water and boiled in a 
water bath for 1 hour with continuous shaking. After cooling, the hydro lysates (3 
ml) were used for formation of alditol acetates of neutral and amino sugars while the 
remaining hydro lysates were reserved for the assay of uronic acid determination 
(details in Section 3.3.4). 
p-D-allose (1 mg/ml), functioned as an internal standard, was added into the 
hydrolysate of each fraction. 12 M ammonia (1.25 ml) was used to neutralize the 
acidic hydro lysates while octan-2-ol (5 |xl) was added as an anti-foaming agent. 
Reduction of the hydro lysates was performed by adding 0.2 ml freshly prepared 
sodium borontetrahydride (200mg/ml) incubated in 40 °C water bath for 30 minutes. 
To stop the reduction, glacial acetic acid (0.1 ml) was added to the reducing 
hydro lysate. Acetylation was achieved by adding acetic acid anhydride (2 ml) and 
1-methylimidzole (0.3 ml). Followed by vortex-mixing at room temperature for 10 
minutes before adding 5 ml distilled water to dissolve the excess acetic anhydride, 
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dichloromethane (1 ml) was added to the mixtures and phase separation was allowed. 
The upper aqueous layer was removed while the lower organic layer was washed 
twice with 2 ml distilled water each time. About 200 mg of anhydrous sodium 
sulphate then removed any water left in the organic layer. The alditol acetate sugar 
products were then stored in a vial at -20 °C before use. Determination of 
derivative sugars was conducted with a HP6890 gas chromatography using an 
Alltech DB-225 capillary column [15 m (L) x 0.25 mm (I.D.), 0.25 |Lim film 
thickness]. The oven temperature program was set as follows: the initial and final 
temperature was at 180 °C and 2 2 0 �C with a temperature increase rate at 4 °C/min. 
Helium was used as the carrier gas. Sample (2 |li1) was injected into the column and 
the neutral monosaccharides in the samples were detected by flame ionization. The 
amount of monosaccharides in each sample was presented as proportion by weight 
(w/w %) and calculated by the following equations: 
Monosaccharide(%) = XxY(mg) ^ 100% (1) 
Sample weight (mg) of GC 
X = Rf (average from replicates) x coefficient (2) 
where the coefficient of hexose 二 1.26; pentose = 1.232; deoxyhexose = 1.246 
Rf — monosaccharide concentration in standard (mg/ml) x 1.5 mix the area of allose in standard 
the area of monosaccharide in standard x 1 mg/ml x 1 ml 
V 一 The area of monosaccharide in samplex 1 mg/ml x 1 ml 
Y " (J)) 
the area of allosein sample 
2.3.3 Protein content determination 
Lowry-Folin method (Lowry et al, 1951; Sapan et al., 1999), which is based on the 
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principles of the Biuret and Folin-Ciocalteau reaction, is a rapid and accurate assay to 
determine the amount of protein existed in the fractions of PU. 
About one miligram of freeze-dried crude hot-water PU extract, PU80, PU60 and 
PU60a and b were accurately weighed and dissolved into 1 ml distilled water before 
the experiment. Sodium hydroxide solution (2N, 0.1 ml) was mixed with 0.1 ml of 
each aqueous sample. The mixtures were hydrolyzed at 100 °C for 10 minutes in a 
boiling water bath. After cooling to room temperature, the hydrolysates were 
further mixed well with 1 ml of freshly prepared complex-forming reagent which 
was composed of 2 % NaaCO〕，1 % CUSO4.5H2O and 2 % sodium potassium tartrate 
in a volume ratio of 100:1:1 and left undisturbed for 10 minutes at room temperature. 
Before measuring the absorbance of the mixtures at wavelength 750 nm with a 
spectrometer (Milton Roy Spectronic 3000)，0.1 ml of Folin-Ciocalteu's phenol 
reagent (BDH) was added to the mixtures which were left at room temperature for 30 
minutes. Blank and standard curve, using distilled water and bovine serum albumin 
(Sigma) ranged from 0 - 500 fig/ml respectively, were prepared and treated as the 
same procedures. The protein content in the PU fractions can be calculated by the 
following equation derived from the BSA standard curve: 
Average absorbance at 750 nm of sample - 0.049 Protein content in sample ("g/ml) = 
2.3.4 Uronic acid content determination 
According to the Official Methods of Analysis 45.4.11 (AO AC, 1996), a colorimetric 
method is typically applied to determine the content of uronic acid in samples. 
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Hydrolysate collected from acid depolymerization in section 2.3.2 was used for the 
determination. An aliquot of 300 \x\ of hydro lysate was mixed thoroughly with 300 
|il of boric acid-sodium chloride solution composed of 2 % sodium chloride solution 
and 3 % boric acid in distilled water. Five millilitres of 2 M concentrated sulfuric 
acid was added to the mixtures with shaking. After incubation at 70 °C for 40 
minutes, the mixtures were cooled down to room temperature and mixed well with 
200 of 0.1 % dimethyphenol in glacial acetic acid with vortex-mixing for 5 
minutes. The mixture was stood at room temperature for 15 minutes before 
measuring its absorbance against blank at wavelengths 400 nm and 450 nm. 
Subtracting absorbance at 400 nm from those at 450 nm was required to correct any 
interference from hexoses in samples. Blank and a standard curve using 2 M 
sulfuric acid and D-galacturonic acid monohydrate ranged from 0 to 800 |ag/ml were 
prepared and treated in the same manners. The amount of uronic acids expressed as 
a polysaccharide residue present in each sample was shown as proportion by weight 
(w/w %). The amount of uronic acids in the PU fractions can be calculated by the 
following equation derived from the D-galacturonic acid standard curve: 
Average absorbance (450 - 400 nm) of sample - 0.050 
Uronic acid content in sample ("g/ml) = ——— 
0.006 
2.3.5 High Performance Liquid Chromatography (HPLC) 
Analytical High Performance Liquid Chromatography (HPLC) is a sophisticating 
technique to determine the purity and molecular weight of samples using very small 
amount of sample volume (|il). Freeze-dried PU fractions (2 %) were completely 
dissolved in 0.5 M sodium chloride solution, then filtered through a sterile filter with 
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0.22 |Lim pore size before loading to a HPLC apparatus (Hewlett Packard series 1100 
HPLC system) equipped with a TSK gel™ column G5000PW [30 cm(L) x 7.5 cm 
(I.D.)，particle size: 17 \xm] (SUPELCO). After conditioning the system, the 
sterile-filtered samples were eluted using 0.5 M sodium chloride solution at a flow 
rate of 0.5 ml/min at 25 °C and detected with Refractive Index (HP 1047A RI 
Detector). Five dextran standards with molecular weights 25，80，270,670 and 788 
kDa were used for constructing a calibration curve for the determination of the 
molecular weight of sample. 
2.4 In vivo Antineoplastic Assay 
2.4.1 Animals 
Two species of mice, BALB/c and athymic BALB/c nude mice were used in this 
project to evaluate the potential of anti-tumor effects of the PU polysaccharides in 
vivo. Both of them were supplied by the Laboratory Animal Service Centre 
(LASEC) of The Chinese University of Hong Kong. 
2.4.1.1 BALB/c mice 
Seven to eight-week-old male BALB/c mice weighed between 20 and 25 g were 
housed eight per plastic cages with wood chip bedding in the Animal House of 
Department of Biology (CUHK) with a 12-h light and 12-h dark cycle at room 
temperature (25 土 2°C). They were allowed free access to standard laboratory diet 
and tap water and acclimated in the laboratory one week before experimentation. 
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2.4.1.2 Athymic BALB/c mice 
Seven to eight-week-old male and female athymic BALB/c nude mice weighed 
between 19 and 24 g were housed in the LASEC and acclimated in the laboratory one 
week before experimentation. The animals were housed in micro isolator cages, six 
per cage, in a 12-h light/dark cycle at a temperature constantly kept at 25 °C. All 
stuffs for the athymic mice including cages, bedding, rodent food and water are 
totally autoclaved before used. 
2.4.2 Maintenance of cell lines 
A murine cell line S-180 and a human cell line MCF-7 were used to study the 
anti-tumor effects of all fractions of PU. Cell line S-180 was provided by American 
Type Culture Collection (ATCC) (Rockville, MD) while cell line MCF-7 was 
supplied from the Institute of Genetics, Fudan University, Shanghai. 
2.4.2.1 Murine sarcoma 180 
Ascitic-form Sarcoma 180 (S-180) was maintained in the peritoneal cavities of male 
BALB/c mice. The cells collected from mouse peritoneum were weekly passed to 
another mouse by the procedures as below. 
S-180 cells in ascitic form were collected from a mouse sacrificed by cervical 
dislocation. The cells were immediately washed twice with 0.45 % PBS by the aid 
of centrifuge (514 g for 5 minutes) (Beckman, Allegra™ 6R centrifuge) and the cell 
- I I -
Chapter 1 
Materials and Methods 
pellet was re-suspended in sterile PBS. With the aid of 0.4 % Trypan blue solution, 
the number of viable cells was counted under a hemocytometer. Cell suspension 
with cell density, 2.5 x cells/ml, was prepared and 0.2 ml of the cell suspension 
which contained 5x10^ cells was intraperitoneally transferred to another mouse. 
2.4.2.2 Human breast cancer cell line (MCF-7) 
MCF-7 cells used in this study were cultured in estrogen-free RPMI 1640 medium 
(Sigma), supplemented with 0.2 % sodium bicarbonate (Sigma), 10 % 
heat-inactivated fetal bovine serum, 100 U/ml of penicillin, 100 |Lig/ml of 
streptomycin and 0.25 ^ig/ml amphotericin B (all from Gibco-BRL). The cells were 
kept in 175 cm^ sterile polystyrene tissue culture flask (Sarstedt) and maintained 
under a folly humidified atmosphere of 95 % room air and 5 % CO2 at 37 °C. 
After 72-hour incubation, the cells were immediately washed twice and re-suspended 
in RPMI-1640 medium. With the aid of trypan blue solution, the number of viable 
cells was counted under a hemocytometer. Cell suspension with cell density, 2.5 x 
10^ cells/ml, was prepared and 0.2 ml of the cell suspension which contained 5 x 10^  
cells was intraperitoneally transferred to the nude mice. 
2.4.3 S-180 tumor inoculation model using BALB/c mice 
S-180 cell suspension with cell density 2.5 x 10^ living cells/ml was prepared as in the 
section 2.4.2.1. Male BALB/c mice under anesthesia by diethyl ether were 
subcutaneously inoculated with 0.2 ml cell suspension into the dorsal area (Day 0) 
(Table 2.1). Five days were allowed for the development of solid tumor in the 
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animals. At Day 5，i.e. five days after tumor inoculation, mice were examined 
carefully by hands and only those bearing solid tumors were selected and randomly 
grouped into 8 per group and caged separately for the use in the experiment. 
2.4.4 MCF-7 tumor inoculation model using athymic nude mice 
MCF-7 cell suspension with cell density 2.5 x 10^ living cells/ml in RPMI 1640 
medium was prepared as in the Section 3.4.2.2. Athymic male and female BALB/c 
mice were subcutaneously inoculated with 0.2 ml cell suspension into the dorsal area 
(Day 0). Seven days were allowed for solid tumor development. At Day 7，i.e. 
seven days after tumor inoculation, mice were examined carefully by hand and only 
those bearing solid tumors were selected and randomly divided into groups of 8 and 
caged separately for the use in the experiment (Clarke, 2002; Liu, 2003) 
2.4.5 Assay of antineoplastic activity with S-180 
After verifying tumor development on mice (Day 5)，crude PU extracts both from hot 
water and cold sodium hydroxide solution, PU80, PU60, PU60a and PU60b were 
intraperitoneally injected into corresponding treatment groups of mice once daily for 
ten consecutive days while sterile PBS was injected, instead of samples, into the 
control groups. 
Ten days after the last i.p. injection of sample (Day 24), the mice were sacrificed by 
cervical dislocation and their body weight was measured. Their tumors were excised 
and measured in terms of weight by an electronic balance and in terms of size using 
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calipers. The tumor volume of each group of mice was determined using the 
following formula (Teicher, 2002; Brady, 2002; Collins, 2003). The anti-tumor 
effects of PU fractions on S-180 solid tumor was expressed as percentage of inhibition 
compared to the control calculated using the following formulae (Kawagishi, 1989): 
2 , , 3 � Long diameter x Short diameter Tumor volume (mm ) = — 
Averagetumor volume of treatment group 1 , Percentageof tumor inhibition (%) = \ \ - — : — f x 100% [ Averagetumor volume of control group 
2.4.6 Assay of antineoplastic activity with MCF-7 
The procedures of the anti-tumor assay with MCF-7 were similar to those described in 
details previously. After verifying tumor development on mice (Day 7)，PU 60b at 
doses of 10 and 5 mg/kg body weight were intraperitoneally injected into 
corresponding treatment groups of mice once daily for ten consecutive days while 
sterile PBS was injected, instead of samples, into the control groups. It was most 
important that all samples including PBS injected into peritoneal cavities of the 
inoculated nude mice should be sterile filtered with 0.22 iiim pore-size sterile filter 
before use. Ten days after the last i.p. injection of sample (Day 24)，the mice were 
sacrificed by cervical dislocation and their body weight was measured. 
Their tumors were excised and measured in term of weight by an electronic balance 
and in term of size using calipers. The average tumor volume of each group of mice 
and percentage of inhibition compared to the control calculated using the above 
mentioned formulae. 
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2.4.7 Body weight change 
In order to assess the side effect of PU fractions, change in body weight was used as 
the parameter. Body weight of each mouse before sample injection and before 
sacrificed was measured. Average change in body weight in each group was 
calculated by the following equation. The change in treatment group was compared 
to the group without tumor inoculation and treatment. 
•“，。/、 Average (Final body weight - initial body w e i g h t ) � ’,細, Percentage change in body weight (%) = ^ . . . . — x 100% Average Initial body weight 
Table 2.1 Schedule for in vivo antitumor assays 
Date , Experiment procedures 
Day 0 i. Tumor inoculation of S-180/ 
MCF-7 cells onto the dorsal ‘ 
sides of the acclimatized mice ‘ 
(s.c) I i 
Day 5 to 14 (for S-180 model) ！ i. Tumor development verification 
Day 7 to 16 (for ]S4CF-7 nMi4el) ii. Body weight measurement of 
I the tumor bearing mice 
! iii. Sample injections (i.p) 
Day 14 to 24 (for S-180 model) i. 10-day Observation 
Day可6 to 26 ( for K^CF-7 model) 
Day25 (for S-180 model) i. Mice Sacrifice by cervical ‘ 
[DayTl f fo rMtF:卞 model) j dislocation 
ii. Body weight measurement i 
iii. Tumor excise 
iv. Tumor weight and size 
.•• "" . '"""""T"'"" 
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2.5 In vitro anti-proliferation assay 
2.5.1 Cell lines 
Five human cancer cell lines: human acute promyelocytic leukemia cell (HL-60), 
human hepatoblastoma cell (HepG2) and human breast cancer cell (MCF-7), human 
colon cancer cell (Colon 201) together with one mouse sarcoma cell (S-180) and one 
monkey kidney normal cells (Vero) were used in this study. Among them, HL-60, 
S-180, HepG2, Colon 201 and Vero were purchased from American Type Culture 
Collection (ATCC), while MCF-7 was obtained from the Institute of Genetics, Fudan 
University, Shanghai. 
2.5.1.1 Maintenance of cell lines 
To prevent unwanted bacterial contamination, 100 unit/ml of penicillin, 100 |ig/ml of 
streptomycin and 0.25 |ig/ml of amphotericin B (all from Gibco-BRL) were added to 
the culture media. 
HL-60, HepG2 and MCF-7 cells were maintained in RPMI 1640 medium (Sigma) 
supplemented with 2 g/L sodium bicarbonate (Sigma) and 10 % heat-inactivated (60 
°C for 60 minutes) fetal bovine serum (Gibco-BRL). 
S-180 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) 
(Gibco-BRL) supplemented with 10 % heat-inactivated fetal bovine serum and 1.5 
g/L sodium bicarbonate. 
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All of the cell lines were cultured in 25 cm^ sterile polystyrene tissue culture flask 
(Sarstedt) with 5 ml of freshly completed medium and incubated at fully humidified 
atmosphere at 37 °C, 5 % CO2 and 95 % room air. The subculture of the cell lines 
were performed three times a week. 
2.5.2 Assay of anti-proliferation with cancer cell lines 
Direct cytotoxicity of samples on cancer cell lines, one possible anti-proliferation 
way to control non-stop cell growth, was investigated by direct incubation of the 
cancer cell line with sample for 72 hours. 
2.5.2.1 Cytotoxicity assay on suspensions of cancer cells 
One hundred microliters of suspensions of HL-60 and S-180 with initial cell density 
of 5 X 10)4 cell/ml were seeded separately in the wells of a sterile 96-welI round 
bottom culture microplates (IWAKI，Japan) and incubated with PU fractions at the 
doses of 50, 100，200 and 400 |ag/ml for 72 hours. The cytotoxic effects of PU 
fractions on HL-60, K-562 and S-180 cells were assessed by the Trypan blue 
exclusion test. 
2.5.2.2 Cytotoxicity assay on adhesive cancer cells 
One hundred microliters of culture medium containing adhesive cells HepG2 and 
MCF-7 with initial cell density of 2 x lO'* cell/ml were seeded separately in the wells 
of a sterile 96-well flat bottom culture microplates (IWAKI, Japan) and acclimated 
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for 24 hours before mixing with 100 \i\ o fPU fractions at the doses of 50，100，200 
and 400 fxg/ml for 72-hour incubation. The cytotoxic effects of PU fractions on 
HepG2 and MCF-7 cells were measured by the MTT assay. 
2.5.2.3 Cytotoxicity assay on normal cells 
Vero cells were used as control to evaluate toxicity of PU fractions on normal cells. 
Because of the adhesive nature of Vero cells, the sample treatments on the cell were 
same as those described in the Section 2.5.2.2. The cell density after 72-hour 
incubation was measured by the MTT assay. 
2.5.3 Trypan blue exclusion method 
The number of viable cells of control and sample-treated cell suspensions after 
72-hour incubation was counted with the aid of the trypan blue dye, which can stain 
only dead cells which have lost their cell membrane integrity but not viable cells. 
One hundred microliters of 0.4 % trypan blue in PBS (w/v) was mixed thoroughly 
using a pipette with equal volume of cell suspensions in each well of 96-well 
microplate for 1 minute. The cell suspensions were gently transferred to a counting 
chamber of a hemocytometer. Only cells lying within the four big corner squares 
were counted. The cell density and viability were calculated by the equations as 
belows: 
广 Total number of cells in the four corner squares of 1 mm 2 
Cell Density = x Dilution factor x 10 cells/ml 
. / � / � Number of viable cells 
Viability (%) = X 100% Total number of cells 
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The value of IC50 of PU fractions on corresponding cell lines was expressed as the 
concentration that exerts 50 % inhibition on cell density compared with control after 
72-hour incubation by the following equation: 
Percentage of inhibition (o/o) = | l - Average cell density of treatment group ！乂⑴。。/。 
[ Average cell density of control group 
2.5.4 MTT assay 
Conversion of soluble yellow tetrazolium salt (MTT) into a dark blue colored 
formazan product in the presence of mitochondrial dehydrogenases released from 
viable cells is the principle of this quantitative colorimetric assay. The number of 
viable adhesive cells is proportional to the amount of blue formazan product which is 
reflected by its color intensity measured using spectrophotometer. Freshly prepared 
MTT (20 |Lil, 5 mg/ml) [3-(4,5-dimethylthiazol-2-yl)-2,5,diphenyl tetrazolium 
bromide] (Sigma) in filtered PBS was added to each well of control and 
sample-treated cells and incubated at 37 °C，5 % C O 2 for 5 hours. The medium was 
discarded and dark blue formazan crystals were remained at the bottom of the wells. 
Acidic isopropanol (150 was added to each well to dissolve the dark blue crystals 
completely by vigorous pipetting. The absorbance at a wavelength 570 nm of the 
solution was measured by microplate reader (SPECTRAmax 250). 
The extent of cell proliferation was indicated as the average value of absorbance 
while anti-tumor effect was showed as percentage of inhibition of sample treated 
groups to control group by the following equation: 
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Percentage of inhibition � ) = { 1 - Average P.P.570nm in treatment group • � / � 
[ Average O.D.570 nm in control group J 
2.6 Cytokine determination 
Cytokines, involved in most disease processes including cancer, play an important 
role in innate immunity, apoptosis and angiogenesis (Baraldi-Junkins, 2000). The 
interaction between cytokines and the cellular immune system is a dynamic process. 
In this study, mouse cytokines were evaluated by a traditional assay, ELISA and a 
novel array system, Mouse Cytokine Array. 
2.6.1 Treatment of mice 
Seven to eight-week-old BALB/c male mice weighing between 20 to 25 g were 
involved in the assays. The acclimated mice were randomly divided into groups of 
10. PU60 and PU60a at the most potent dose of 10 mg/kg was introduced daily to 
the treatment groups for 10 consecutive days while sterile PBS was used instead for 
intraperitoneal injection into the control group. At the day of the last sample injection 
and 10 days after injection, 10 p,g of lipopolysaccharide (LPS) in 0.2 ml sterile PBS 
was injected intravenously (i.v.) into each mouse one hour before blood collection. 
Half of the treatment and control groups received LPS stimulation while the remaining 
half of treatment and control groups did not. 
Mouse blood was collected by making a cut on the veins of mouse tails an hour after 
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LPS treatment. The blood was left undisturbed at room temperature for an hour prior 
to centrifugation at 1000 g for 15 minutes (Jouan A-14 centrifuge). The blood pellet 
was discarded and the supernatant was collected as serum sample for TNF-a assay. 
The serum was stored at -20 °C until used. 
2.6.2 Enzyme-linked immunosorbent assay (ELISA) for TNF-a production 
The amount of TNF-a in the mouse sera was revealed with the aid of a sandwich 
ELISA kit, Mouse TNF-alpha ELISA Ready-SET-Go! (eBioscience). The 
experimental procedures suggested by the supplier were followed as note below: 
One hundred micro liters/well of capture antibody (purified pre-titrated anti-mouse 
TNF-a) in coating buffer were coated on the surfaces of 96 wells of Nunc Maxisorp 
microplate. The capture-antibody containing microplate was sealed with parafilm 
and incubated overnight at 4 °C. The wells of the plate were aspirated and washed 
three times with 320 ^il/well of wash buffer which contains 0.05 % Tween 20 in 
sterile PBS. After removing any residual buffer from each well, the wells were 
blocked with 200 |Lil/well of assay diluent and incubated at room temperature for one 
hour. The wells were aspirated and washed three times after 1-hour blocking as the 
previous steps. Diluted mouse serum (100 |li1, 1:20) was added into each 
antigen-coated well as primary antibody. The plates were sealed and incubated at 
room temperature for 2 hours. The plates were aspirated and washed five times 
with wash buffer as the previous steps. One hundred micro liters/we 11 of detection 
antibody (biotin-conjugated pre-titrated anti-mouse TNF-a cocktail) in assay diluent 
were added into each well. The plate was further incubated at room temperature for 
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an hour. After aspirating and washing five times as above, one hundred microliters 
/well of detection enzyme (pre-titrated Avidin-HRP) diluted in assay diluent was 
added into each well. The plates were incubated at room temperature. After 30 
minutes, the wells were soaked in wash buffer for 1 minute prior to aspiration. This 
step was repeated for seven times. One-hundred micro liters/well of TMB (3，3’，5， 
5'-tetramethylbenzidine) substrate solution was added to each well and the plate was 
kept in darkness for 15 minutes. The experiment was completed by adding 50 
|al/well of stop solution (1 M Phosphoric Acid) to each well. The absorbance of each 
well at the wavelength 450 nm was determined by the microplate reader at a reference 
wavelength of 570 nm. A standard calibration curve was prepared in the same 
manners using recombinant mouse TNF-a which was diluted two-fold of the stock 
standards, 1000 pg/ml. 
2.6.3 Analysis of mouse cytokine array 
2.6.3.1 Process of blocking and incubation 
Mouse Cytokine Array (RayBio™ Mouse Cytokine Array) is the first commercially 
available cytokine protein array system. The kit provides a simple array format 
which can accurately and simultaneously identify the expression profiles of multiple 
cytokines from mouse sera in several hours. 
Each membrane with an antibody-printed side of RayBio™ Mouse Cytokine Array 
was placed separately into the provided eight-well tray. Two milliliters of blocking 
buffer provided by the kit was overlaid on the membranes which were then incubated 
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overnight at 4 °C. The blocking buffer was gently discarded from the wells and one 
mililiter of serum sample diluted by blocking buffer (1:10) from the mice in treatment 
and control groups was separately added to the membranes and allowed to be 
incubated at room temperature for 2 hours. The serum samples were decanted from 
each well and the membranes were washed three times with 2 ml of provided wash 
buffer I with shaking. Each washing was last for 5 minutes. The membranes were 
further washed twice with 2 ml of provided wash buffer II with shaking. Each 
washing was also last for 5 minutes. One milliliter of 250-fold diluted 
biotin-conjugated antibodies was added to each membrane which was incubated at 
room temperature. After 2-hour incubation, the membranes were washed three times 
with wash buffer I and twice with wash buffer II as mentioned above. Finally, two 
milliliters of 1000-fold diluted HRP-conjugated streptavidin was added to each 
membrane and the membranes were further incubated at room temperature for 45 
minutes. Before the detection process, the membranes were washed again following 
the above-mentioned washing steps. 
2.6.3.2 Process of cytokine detection 
Five-hundred microliters of provided detection buffer A and 500 |li1 of provided 
detection buffer B were mixed and added to the membrane. Incubation was allowed 
at room temperature for 5 minutes. Excess detection reagent was drained off by 
holding the membrane vertically with forceps. The membranes with protein sides 
facing upwards were gently dried with Kimwipe. The dried membranes were 
wrapped with Saranwrap and exposed to x-ray films (Fuji medical film) for 45 minutes 
before signal detection using film developer. 
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2.7 Statistical Analysis 
For statistical analysis of the data, the Student's /-test was applied to compare the 
levels of treatment group with those of the control groups. The results were 
expressed either as mean 士 standard deviation (S.D.) or standard error of the mean 
(S.E.M.). The data were defined as significant and very significant if p<0.05 and 
p<0.01 respectively. 





3.1 Extraction of Polyporus umbellatus polysaccharides (PU) 
3.1.1 Percentage of Yield in extraction of crude PU extracts 
In the extraction with hot water, 176.95 g crude water extract (PUw) was isolated 
from 700 g dried sclerotia of Polyporus umbellatus. On average, 100 g dried 
sclerotia might produce 25 g PUw. In alkaline extraction, 239.64 g crude alkaline 
extract (PUAL) was obtained from 700 g of the cooked residue of ground Polyporus 
umbellatus sclerotia. On average, 100 g cooked residue might produce 34 g P U A L 
(Table 3.1). 
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3.1.2 Percentage of yield in fractionation of PU fractions 
From 200 g of powder-form PUw under 60 % and 80 % ethanol precipitation, 0.96 g 
PU60 and 2.28 g PU80 were respectively isolated (Table 3.2). For further 
fractionation of the crude PU60 polysaccharides by anion exchange chromatography, 
application of 80 mg PU60 resulted in two fractions, PU60a and PU60b. 0.319 mg 
unbound component (PU60a) on DEAE-cellulose was eluted with distilled water 
while 4.527 mg retained component (PU60b) on DEAE-cellulose was eluted with 
0.15 M NaCl (Figure 3.1). Recovery of the PU60 fractions after anion exchange 
chromatography was 6.06 % (Table 3.3). 
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Table 3.1 Percentage yield of PU fractions extracted from 700 g dried sclerotia of 
Polyporus umbellatus. 
Product Color Weight (g) Yield (%)' 
Hot-water soluble PU (PUw) Brown 176.95 ^ 
Alkaline soluble P U (PUAL) Dark Brown 239.64 34.2 
�% Yield = (weight of the fraction obtained/ 700 g of the dried sclerotia of Polyporus 
umbellatus) xlOO% 
Table 3.2 Percentage yields of PU60 and PU80 after ethanol precipitation of 200 g 
PUw. 
Product C ^ Weight (g) Yield (%)" 
'PU60 Pale Brown 048 
#PU80 Brown 2.28 1.14 
b % Yield = (weight of the fraction obtained/ 2 0 0 g of the freeze-dried P U w ) x 100 % 
"PU60 fraction was obtained from ethanol precipitation up to 60 % final concentration. 
PU80 fraction was obtained from ethanol precipitation up to 80 % final concentration. 
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Table 3.3 Recovery of PU fractions after application of 80 mg PU60 to 
DEAE-cellulose column. 
Product Color Weight (mg) Yield (%) 
PU60a Whit^ 0 l i 9 040^ 
PU60b Very pale brown 4.527 5.66' 
Total — 4.846 6.06 d 
‘% Yield =( weight of the fraction obtained/80 mg PU 60) x 100 % 
d Recovery of total fractions after fractionation = total weight of all fractions / 80 mg 
PU60) X100% 




























































































































































































































































































3.2 Chemical characterization of PUw fractions 
3.2.1 Carbohydrate and protein contents of PUw fractions 
Carbohydrate and protein contents of PUw fractions were determined by phenol 
sulfuric acid assay and Lowry method, respectively (Table 3.4). Percentage of 
carbohydrate content of hot-water crude extract was 77.09 while those of its two 
ethanol-precipitated polysaccharides PU60 and PU80 were 82.01 and 85.76 
respectively. Among the two fractions of PU60, PU60b contained much more 
carbohydrate (90.66 %) than PU60a did (78.56 %). 
According to the Lowry method, PUw contained 2.93 % of protein. The highest 
protein content among the five fractions is 15.85% (PU80) while the lowest protein 
content is 0.55 % (PU60a). 
3.2.2 Relative content of monosaccharides and uronic acid in PUw fractions 
The relative content of monosaccharides and uronic acid in the four PUw fractions 
were determined by gas chromatography and colorimetric carboazole assay 
respectively. As listed in Table 3.5, glucose was the chief monosaccharide existing 
in all samples. Among the ten kinds of monosaccharides, only fucose and 
galactosamine failed to be detected in the samples. The results demonstrated that 
PUw contained trace amount of arabinose, mannose, ribose, xylose and glucosamine; 
PU80 contained trace amount of arabinose, galactose, mannose, rhamnose and ribose. 
The monosaccharide compositions of PU60 and PU60b were almost the same. The 
only difference between them is their proportion. Besides glucose, PU60a 
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contained galactose, mannose, glucosamine, arabinose, and rhamnose in decreasing 
order but had no uronic acid. The colorimetric assay revealed that all tested 
samples contained very little uronic acid (< 2.5%) and even PUw contained no uronic 
acid at all. 
- 5 6 -
Chapter 3 
Results 
Table 3.4 Carbohydrate and Protein contents in PUw fractions. 
Fractions Carbohydrate Content (%) Protein Content (%) 
PU^ 77.09 ± 0.3 2.93 士 0.4 
PU8G 85.76 士 0.1 15.85 ±0.2 
PU60 82.01 土 0.2 12.62 土 0.1 
78.56 土 0.3 0.55 ±0.2 
90.66 ±0.1 4.75 ± 0.0 
Carbohydrate and Protein contents were respectively determined by the 
Phenol-sulfuric assay and Lowry method. 
The results were expressed as mean 土S.D. 
M 
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Table 3.5 Proportions of different monosaccharides and uronic acid in the five PUw 
fractions determined by Gas Chromatography and colorimetric method. 
Proportions ( % w/w f 
Monosaccharides ^ ^ p u 6 0 PU60a PU60b 
Galactose I ^ ^ 3 M 1^52 
Mannose 35.56 3.71 3.98 3.38 3.17 
Fucose - - - - -
Galactosamine - - - + -
Glucose 49.54 93.17 92.29 32.31 90.41 
Rhamnose - 1.39 1.63 0.39 1.44 
Ribose 5.97 + + + -
Arabinose + 1.71 2.07 0.42 1.63 
Xylose 5.94 - + - + 
Glucosamine 2.99 — 0.01 2.86 1.83 
Uronic acid - 2.38 2.1 - 1.92 
a The results are expressed as relative proportions (% w/w) in each fraction 
“ + ” indicates that only trace amount (> 0.001 %) of monosaccharide was 
detected. 
“-“indicates that the particular monosaccharide was not detectable. 
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3.2.3 Infrared spectra of PUw fractions 
Fractions PUw, PU60 and PU60a were completely dehydrated in a desiccator. 
Dried fractions (10 mg) were used for the IR spectrum test at 40000 - 500 cm"^  by 
the KBr tablet method. The hot-water crude extract PUw had no characteristic 
absorption (data not shown). By contrast, PU60 and PU60b exhibited sharp IR 
absorption at 890 cm'^ indicating that p-pyran glycosidic bond was present in the 
two fractions (Figure 3.2). 
3.2.4 Molecular weight estimation of PUw fractions 
The molecular weights of the crude PUw, PU60, PU60a and PU60b were estimated 
by measuring the retention time of the sample compared with those of dextran 
standard (Figure 3.3) with the aid of HPLC. The corresponding chromatograms 
were shown in Figure 3.4 and Figure 3.5. 
A salt peak appeared in each elution curve of PU fractions at a retention time of 
about 25.5 minute. The molecular weight of PUw was about 6.14 kDa. PU60 was 
a heterogenous polysaccharide fraction with a molecular weight ranging from 19.7 to 
607.0 kDa and about 93 % of PU60 was about 19.7 kDa in size (Figure 3.4b). 
Similarly, PU60b was also a heterogenous polysaccharide fraction with a molecular 
weight ranging from 21.45 to 607 kDa. About 90.4 % of PU60b eluted at 22.87 
minute was about 21.45 kDa in size (Figure 3.5b). PU60a was relatively 
homogenous showing in the Figure 3.5a in the form of a small peak. Its molecular 
weight was about 20.31 kDa. 
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Figure 3.2 Infrared Spectra of (a) PU60 and (b) PU60b. 
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Figure 3.3 Standard curve of HPLC indicating retention time of the four dextran 
standard with molecular weights of 25，80，270 and 670 kDa. 
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Figure 3.4 Gel permeation of (a) PUw and (b) PU60 by HPLC. 
Molecular weight of PU60 fractions was determined by HPLC using 
dextran standards with molecular weights of 25, 80, 270 and 670 kDa. 
Freeze-dried PU fractions (2 %) were completely dissolved in 0.5 M sodium 
chloride solution and filtered through a sterile filter with 0.22 fim pore size 
before loading to a HPLC apparatus. 
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Figure 3.5 Gel permeation of (a) PU60a and (b) PU60b by HPLC. 
Molecular weight of PU60 fractions was determined by HPLC using 
dextran standards with molecular weights of 25, 80’ 270 and 670 kDa. 
Freeze-dried PU fractions (2 %) were completely dissolved in 0.5 M sodium 
chloride solution and filtered through a sterile filter with 0.22 jim pore size 




3.3 In vitro anti-proliferative assay 
3.3.1 Anti-proliferative effects of PU fractions on suspension cancer cell lines 
The in vitro effects of crude cold-alkaline extract (PUAL), hot-water extract (PUw) 
and polysaccharide fractions, PU80 and PU60 on proliferation and viability of HL-60 
cells and S-180 cells were evaluated by Trypan blue exclusion method. 
Macroscopically, PU fractions showed no remarkable anti-proliferative effect on both 
S-180 (Figure 3.6) and HL-60 cells; on the contrary, all PU fractions (PUw, P U A L , 
PU80 and PU60) might enhance the proliferation of HL-60 cells ranging from 20.9% 
to 58.1% (Figure 3.7). The viability of S-180 cells under the fraction treatment was 
over 96%, which was higher than that of HL-60. 
3.3.2 Anti-proliferative effects of PU fractions on adhesive cancer cell lines 
The in vitro effects of the two crude extracts PUAL and PUw, together with crude 
polysaccharide fractions, PU80 and PU60 on proliferation of MCF-7, HepG2 and 
Colon 201 were evaluated by MTT assay. The results were expressed in the mean 
absorbance of wavelength at 570 nm 士 S.D. 
Microscopically, all fractions had no consistent anti-proliferative effect on the three 
adhesive cancer cell lines. Both PUAL and P U 8 0 exhibited weak anti-proliferative 
effect on MCF-7 cells (Figure 3.8) but appeared to promote cell proliferation on 
HepG2 and Colon 201 (Figure 3.9 and Figure 3.10). The highest inhibition ratios of 
PUAL and PU80 on MCF-7 cell density were 12.3 % (400 |ag/ml) and 12 % (400 




HepG2 and Colon 201 at each dose. On the other hand, both PUw and PU60 
demonstrated fluctuated results when treated with MCF-7, HepG2 and Colon 201 at 
doses of 100 |ag/ml, 200 |Lig/ml and 400 |xg/ml (Figure 3.8，Figure 3.9 and Figure 
3.10). In brief, PUw might slightly inhibit proliferation of MCF-7 at 200 |Lig/ml and 
400 |Lig/ml while it might enhance HepG2 proliferation at the three doses, which was 
totally opposite to the effects of PU60 on HepG2. 
3.3.3 Anti-proliferative effects of PU fractions on normal cell lines 
The cytotoxicity of PU fractions was evaluated using a normal cell line, Vero cell, 
which is a normal monkey kidney cell line with the aid of MTT assay performed the 
same manner as mentioned above. The four PU fractions show no any significant 
cytotoxicity towards Vero cell line (Figure 3.11). 
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Table 3.6 Percentage of inhibition on proliferation of S-180 
Fraction % of inhibition at different concentrations 
100 )ig/ml 200 |ig/ml 400 i^g/ml 
PUAL - 7 . 3 3 - 8 . 6 1 - 1 0 . 0 4 
PUw - 1.64 + 24.27 +30.11 
PU80 - 6.87 - 15.27 - 9.73 
PU60 - 1.33 - 6.83 - 16.67 
140 
� ' 2 � ： “ ‘ 
i 80 - ^ f — — = 1 * 
目 6 0 -
1 40 - + P U W 
U ‘ PU60 
_ + PU80 
20 -
• PUAL 
Q I I I I I 1 1 1 I 
0 50 100 150 200 250 300 350 400 450 
Concentration ()j,g/ml) 
Figure 3.6 The effects of PU fractions on proliferation of S-180 cell line after 72 h 
incubation. 
With the aid of Trypan blue method, antiproliferative effects on S-180 cell 
line were evaluated after 72 h incubation with PU fractions at doses of 
100 Jdg/ml, 200 jLLg/ml and 400 jug/ml respectively. The results were 
expressed as mean of cell density (l(f cells/ml) 土 S.D. of three replicates. 
The Student's t-test was applied. The data were defined as significant 
and very significant difference from control group if p < 0.05�*�and p < 
0.01 (**)• 
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Table 3.7 Percentage of inhibition on proliferation of HL-60 
Fraction % of inhibition at different concentrations 
100 i-ig/ml 200 [ig/m\ 400 |ig/ml 
PUAL - 3.24 + 16.21 +20.9 
PUw + 17.38 +31.29 +35.08 
PU80 + 12.15 + 17.06 +26.4 
PU60 + 45.42 +53.4 +58.1 
140 � 
120 - —— * 
f ^ ^ ^ ^ ^ ^  
� 1 0 0 - - ^ ^ ^ ^ J 
i 80 
•55 
§ 60 -T3  = + P U W � 4 0 - -—PUAL 
士 PU60 
20 _ HI~PU80 
Q I I I 1 1 1 1 1 1 
0 50 100 150 200 250 300 350 400 450 
Concentration (|j,g/ml) 
Figure 3.7 The effects of PU fractions on proliferation of HL-60 cell line after 72 h 
incubation. 
With the aid of Trypan blue method, antiproliferative effects on HL-60 
cell line were evaluated after 72 h incubation with PU fractions at doses 
of 100 jig/ml, 200 jlg/ml and 400 jdg/ml respectively. The results were 
expressed as mean of cell density (IG^ cells/ml) 士 S.D. of three replicates. 
The Student's t-test was applied. The data were defined as significant 
and very significant difference from control group if p < 0.05 (*) and p < 
0.01〈**〉. 
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Table 3.8 The effects of PU fractions on viability of S-180 and HL-60 cell lines 
after 72 h incubation. 
~ F r a c t i o n s Concentration Viability (o/o) 
(Hg/ml) S-180 HL-60 
0 9 9 . 3 6 ± 0 . 0 1 9 5 . 4 1 ± 0 . 0 1 
PUal 1 0 0 9 6 . 6 4 ± 0 . 0 1 90.89 士 0 . 0 1 
200 9 7 . 3 3 士 0 . 0 2 88.40 士 0 . 0 2 
4 0 0 9 6 . 5 1 ± 0 . 0 1 8 1 . 3 9 士 0 . 0 1 
PUw 1 0 0 98.97 士 0.01 9 8 . 2 6 士 0 . 0 3 
2 0 0 9 9 . 2 4 士 0 . 0 1 8 6 . 7 5 ± 0 . 0 6 
4 0 0 9 9 . 8 3 士 0 . 0 1 7 8 . 3 6 士 0 . 0 5 
PU80 100 97.01 ±0.00 96.15 士 0.02 
2 0 0 9 8 . 6 5 士 0.00 96.60 土 0 . 0 1 
4 0 0 9 8 . 7 2 ± 0 . 0 1 9 4 . 3 9 士 0 . 0 1 
PU60 100 98.18 士 0.01 88.21 士 0.04 
2 0 0 9 7 . 7 8 土 0 . 0 0 8 5 . 7 3 士 0 . 0 0 
4 0 0 9 6 . 5 7 士 0 . 0 1 80.62 士 0 . 0 1 





Table 3.9 Percentage of inhibition on proliferation of MCF-7 
Fraction % of inhibition at different concentrations 
100 |ig/ml 200 \xg/ml 400 [ig/ml 
P U A L - 3 . 9 - 9 . 7 - 1 2 . 3 
PUw + 8 . 9 -8 .3 - 8 . 8 
PU80 -8.5 -7.8 -12.0 
PU60 -5.8 -0.9 +13.9 
1.4 -
* PUw 
i 1.0 i* 
ts 0.8 -(U 0 
1 0.6 -
J + P U W 
^ 0.4 - —PUAL 
+ PU60 
0.2 “ • PU80 
0 . 0 ‘ ‘ ‘ ‘ ‘ 
0 100 200 300 400 500 
Concentration (jj,g/ml) 
Figure 3.8 The effects of PU fractions on proliferation of MCF-7 cell line after 72 h 
incubation. 
With the aid of MTT assay, antiproliferative effects on MCF-7 cell line were 
evaluated after 72 h incubation with PU fractions at doses of 100 jUg/ml, 200 
lig/ml and 400 /LLg/ml respectively. The results were expressed as mean of 
absorbance at 570 nm 土 S.D. of three replicates. 
The Student 's t-test was applied and the data were defined as significant and 
very significant difference from control group if p < 0.05�*) and p < 0.01 
鬥 . 
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Table 3.10 Percentage of inhibition on proliferation of HepG2 
Fraction % of inhibition at different concentrations 
100 |Lig/ml 200 iig/ml 400 i^g/ml 
P U A L +42.2 +43.1 +35.0 
PUw +5.0 +12.0 +4.5 
PU80 +34.3 +17.3 +8.3 
PU60 -3.6 -11.9 -15.0 
1.2 -
T X.  
S 工 …-- 一 J 
1 . 0 _ * * PU80 一~* 
£ y ^ ^ ^ ^ ^ ^ ^ ^ 干 * P U 8 0 
- ^ — — - , 
I 0.6 - ^ 
o  ；I 0.4 - + P U W 
+ PUAL 
0.2 - + P U 6 0 
hb~pu80 
0 . 0 ‘ ‘ ‘ ‘ ‘ 
0 100 200 300 400 500 
Concentration (昭/ml) 
Figure 3.9 The effects of PU fractions on proliferation of HepG2 cell line after 72 h 
incubation. 
With the aid of MTT assay, antiproliferative effects on HepGl cell line were 
evaluated after 72 h incubation with PU fractions at doses of 100 fig/ml, 200 
flg/ml and 400 jlg/ml respectively. The results were expressed as mean of 
absorbance at 570 nm 土 S.D. of three replicates. 
The Student 's t-test was applied and the data were defined as significant and 
very significant difference from control group if p < 0.05 (*J and p < 0.01 
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Table 3.11 Percentage of inhibition on proliferation of Co Ion 201 
Fraction % of inhibition at different concentrations 
100 fig/ml 200 [ig/m\ 400 昭/ml 
PUAL +25.2 +62.2 
PUw -16.9 +12.8 -5.2 
PU80 +6.9 +46.3 +39.0 
PU60 -6.2 +3.1 +25.5 
0 . 7 「 
0.6 - I ^ 
："* PUA,. 
Z … — — . . … . . 1 . . — 
c 0.5 - 乂 I ——-
, 0 . 4 - z z 1 * P U 6 0 
2 
I 0.3 - ^ ^ ^ ^ ^ ^ 
I I* PUw 
J 0.2 - +PUW 
< —PUAL 
0.1 - + P U 6 0 
• PU80 
0.0 ‘ ‘ ‘ ‘ ‘ ‘ ^ ‘ ‘ 
0 50 100 150 200 250 300 350 400 450 
Concentration (|ag/ml) 
Figure 3.10 The effects of PU fractions on proliferation of Colon 201 cell line after 
72 h incubation. 
With the aid of MTT assay, antiproliferative effects on Colon 201 cell 
line were evaluated after 72 h incubation with PU fractions at doses of 
100 jig/ml, 200 jig/ml and 400 jig/ml respectively. The results were 
expressed as mean of absorbance at 570 nm 士 S.D. of three replicates. 
The Student's t-test was applied and the data were defined as 
significant and very significant difference from control group i f p < 0.05 
(*) andp< 0.01�**;• 
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Table 3.12 Percentage of inhibition on proliferation ofVero cell 
Fraction % of inhibition at different concentrations 
100 |ig/ml 200 )ig/ml 400 i^g/ml 
PUAL + 1 0 T 6 ^ 
PUw +5.0 -0.5 -1.0 
PU80 +1.4 +10.0 +5.0 
PU60 -0.7 -2.0 +1.0 
1.4 -
1.2 - T 
1 1.0 
2 0.8 — 0 c 
1 0.6 -
：< - ^ P U W 
0.4 _ -^PUAL 
+ PU60 
0.2 _ • PU8Q 
0 . 0 ‘ ‘ ‘ ‘ ‘ 
0 100 200 300 400 500 
Concentration (jig/ml) 
Figure 3.11 The effects of PU fractions on proliferation of normal cell line (Vero) 
after 72 h incubation. 
With the aid of MTT assay, cytotoxic effects on Vero cell line were 
evaluated after 72 h incubation with PU fractions at doses of 100 jlg/ml, 
200 jLLg/ml and 400 }ig/ml respectively. The results were expressed as 
mean of absorbance at 570 nm ±S.D. of three replicates. 
The Student 's t-test was applied and the data were defined as significant 
and very significant difference from control group if p < 0.05 (*) and p < 
0.01 r*;. 
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3.4 In vivo antineoplastic assay 
3.4.1 S-180 tumor inoculation model using BALB/c mice 
3.4.1.1 In vivo antineoplastic effect of crude extracts - PUw and P U A L 
The hot-water crude extract (PUw) and cold-alkaline crude extract (PUAL) were used 
in the preliminary in vivo antineoplastic assay using Sarcoma 180 tumor bearing 
BALB/c mice. One-hundred milligrams/kg of PUw and P U A L were intraperitoneally 
injected into the tumor bearing BALB/c mice respectively for 10 consecutive days. 
Antineoplastic effects on S-180 solid tumor in mice were expressed as percentage of 
inhibition to the control group. In shown in Figure 3.12, hot-water extract PUw had 
antineoplastic effect (76 %) higher than that of P U A L (68%) and only PUW-treatment 
group showed complete tumor regression (14 %). Mortality of the three groups of 
mice was low, but comparatively, PUAL treatment group had the highest mortality 
among the three groups. 
3.4.1.2 In vivo antineoplastic effect of PUw 
This assay was done in order to determine the effective range of dose of PUw. 
Antineoplastic effects on S-180 solid tumor in mice were expressed as percentage of 
the control level. Figure 3.13 showed that PUw exhibited dose-dependent effect 
only at the low doses ranging from 12.5 mg/kg to 50 mg/kg. The most potent dose 
was 100 mg/kg which significantly exhibited 79 % inhibition on tumor growth while 
a dose of 12.5 mg/kg might inhibit tumor growth by 69 %. 
Initial and final body weights of the tested mice were measured and the record was 
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showed in Table 3.15. All mice in the treatment groups did not reduce their body 
weight in the end of experiment. The percentage of body weight gain of the 
treatment groups with doses of 12.5 mg/kg and 50 mg/kg respectively were higher 
than that of control group. 
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Table 3.13 The effect of PUAL and PUw on S-180 tumor bearing BALB/c mice 
T r e a t m e n t n Average Tumor weight (g) M o r t a l i t y ,  士 S.E.M. J Regression 
Control 7 0.921 ±0.204 2 0 
PUAL 7 0.295 士 0.098 3 0 
PUw 7 0.218 士 0.043 1 1 
“The tumors were excised and weighed 10 days after 10-day observation and the 
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Figure 3.12 The Effects of crude extracts (Pw and PAL) on Sarcoma 180 solid 
tumor in vivo. 
S-180 tumor bearing mice were induced by subcutaneous injection of 5 x J(f 
cells (suspending in 0.2 ml sterile PBS) into the dorsal side of male BALB/c 
mice. 5 days after tumor inoculation, PBS, PUw and PUAL at the dose of 
100 mg/kg were daily injected intraperitoneally into the tumor bearing mice 
for 10 consecutive days. 
Antineoplastic effects on S-180 solid tumor in mice were expressed as 
percentage of inhibition to the control group. Statistically significant values 
were respectively indicated with * and **forp <0.05 andp <0.01. 
- 7 5 -
Chapter 3 
Results 
Table 3.14 The effects of PUw in different concentrations on S-180 tumor bearing 
BALB/c mice 
Complete b * t iTumor 
Treatments Mortality Tumor AverageTumor 
Regression weight (g) 土 S.E.M. rati�（o/。） 
"Control PBS 2/8 0/8 0.921 ±0.198 0  
PUw 12.5mg/kg i i i 0/8 0.283 ±0.100 ^ 
25 mg/kg 1/8 0/8 0.338 ±0.153 63 
50 mg/kg 2/8 0/8 0.393 ±0.094 57 
100 mg/kg 0/8 1/8 0.194 士 0.051 79 
“The row expressed the results of control group for PUw treatment assay. 
''The average tumor weight was expressed in the unit (g) ± S.E.M. 
c Tumor inhibition ratio = (average tumor weight of treatment group- that of control group)/ 
average tumor weight of control group x 100 % 
1 0 0 � • 
Co 90 - • 
� o - • 
M 70 - • • 1 n 
I 50 1 1 * * 
B i i B 
PBS 12.5 25 50 100 
Concentration (mg/kg) 
Figure 3.13 Effects of hot-water crude extract PUw in different concentrations on 
Sarcoma 180 solid tumor in vivo. 
PUwat doses of 100 mg/kg, 50 mg/kg and 25 mg/kg and 10 mg/kg were daily i.p. injected into the 
tumor bearing BALB/c mice for 10 consecutive days and PBS was used as control. 
Antineoplastic effects on S-180 solid tumor in mice were expressed as percentage of control level 
(Average tumor weight of treatment group/Average Tumor weight of control x 100%). Statistically 
significant values were respectively indicated with * and **forp <0.05 andp <0.01. 
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Table 3.15 Effects of hot-water crude extract PUw in different concentrations on 
body weight of S-180 tumor bearing mice. 
"Average Body Weight (g) 士 S.D. Treatments ————：   
Initial Final 
Control PBS 22.18 ± 1.35 23.88 ±1.76 
12.5mg/kg 22.88 ± 1.46 25.11 ±1.06 
25 mg/kg 23.16 ± 1.76 23.81 土 1.95 
50 mg/kg 23.54 土 1.23 25.41 士 1.49 
100 mg/kg 23.64 ± 1.35 24.19 ±1.26 
S-180 tumor bearing mice were induced by subcutaneous injection of 5 x 
/ 
10^ cells (suspending in 0.2 ml sterile PBS) into the dorsal side of male 
BALB/c mice. 5 days after tumor inoculation, PBS and PU60 at doses of 
100 mg/kg, 50 mg/kg, 25 mg/kg and 12.5 mg/kg were daily injected 
intraperitoneally into the tumor bearing mice for 10 consecutive days. 
The average tumor weight was expressed in the unit (g) 士 S.D. The 
initial body weight of mice was measured after tumor development 
verification (i.e. the first day of sample injection) and the final body 
weight was measured after the enucleation of the tumor from the mice. 
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3.4.1.3 In vivo antineoplastic effect of PU60 and PU80 
Doses of 100 mg/kg, 50 mg/kg and 10 mg/kg of PU60 and PU80 were respectively 
injected intraperitoneally into the mice. Between the two fractions, PU60 exhibited 
tumor inhibition effect stronger than PU80 did on the whole (Table 3.16). Both 
PU60 and PU80 had no obvious dose-dependent effect on tumor inhibition. The 
mice treated with 100 mg/kg PU60 showed the highest tumor inhibition percentage 
(80 %) when compared with the control groups. The second highest tumor 
inhibition effect (77 %) was not due to the dose of 50 mg/kg but 10 mg/kg (Table 
3.16). On the other hands, the dose giving the highest tumor inhibition percentage 
of PU80 was 10 mg/kg (76 %) but the antineoplastic effect of PU80 declined when 
the concentrations ofPUSO were increased. 
As expected, all mice in the treatment groups did not reduce their body weight in the 
process of experiment. The percentage of body weight gain of the treatment groups 
was higher than that of the control group. 
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Table 3.16 The effects of polysaccharide fractions PU60 and PU80 in different 
concentrations on Sarcoma 180 solid tumor in vivo. 
Complete ® Average Tumor ''Tumor Treatments Mortality Tumor volume (mm^) 土 inhibition 
Regression S.E.M. ratio (%) 
' C o n t r o l P B S 3/10 351.06 土 29.10 0 
PU60 10 mg/kg 1/7 0/7 82.10 土 12.60 77 * 
50 mg/kg 0/7 0/7 88.50 土 17.30 75 * 
100 mg/kg 1/7 1/7 70.78 ± 17.70 80 * 
b C o n t r o l ？ 0 / 8 0/8 494.82 ±29.40 0 
PU80 10 mg/kg 0/8 0/8 119.06 土37.86 76 
50 mg/kg 0/8 0/8 202.13 土 61.32 59 
100 mg/kg 0/8 0/8 177.70 ±75.23 64 
PU80 and PU60 at doses of 100 mg/kg, 50 mg/kg and 10 mg/kg were daily injected (i.p.) into 
the tumor bearing BALB/c mice for 10 consecutive days and PBS was used as control. 
Antineoplastic effects on S-180 solid tumor in mice were expressed as percentage of tumor 
inhibition. Statistically significant values were respectively indicated with * and ** for p < 
0.05 andp <0.01. 
° The item expressed the results of control group for PU60 treatment assay, 
b The item expressed the results of control group for PU80 treatment assay, 
c The tumors were excised and measured with a caliper 10 days after 10-day treatment and 
the average tumor volume was expressed in the unit (mm^) 士 S.E.M. 
d % Tumor inhibition ratio (%) = [1- (Average tumor volume of treatment group/Average 
tumor volume of control group)] X100% 
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Table 3.17 The effects of polysaccharide fractions PU60 and PU80 in different 
concentrations on body weight of S-180 tumor bearing mice. 
^Average Body Weight (g) 士 S.D. Treatments  Initial Final 
Control PBS 23.91 ± 1.38 25.08 ± 1.90 
PU60 lOmg/kg 24.32 土 0.44 25.67 ±0.72 
50 mg/kg 24.94 土 1.39 25.86 土 1.90 
100 mg/kg 25.09 ± 1.31 26.52 ±1.69 
Control PBS 24.59 ± 1.45 24.82 ±1.80 
PU80 10 mg/kg 24.52 ±0.52 25.50 ±1.00 
50 mg/kg 24.55 士 1.10 24.89 ±1.09 
100 mg/kg 24.15 土 0.62 24.69 士 0.60 
PU80 and PU60 at doses of 100 mg/kg, 50 mg/kg and 10 mg/kg were daily 
injected intraperitoneally into the tumor bearing mice for 10 consecutive 
days and PBS was used as control. 
The average tumor weight was expressed in the unit (g) 士 S.D. The 
initial body weight of mice was measured after tumor development 
verification (i.e. the first day of sample injection) and the final body 
weight was measured after the enucleation of the tumor from the mice. 
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3.4.1.4 In vivo antineoplastic effect of PU60a and b 
After screening out the PU80, PU60 was further fractionated with the aid of DEAE 
column, producing PU60a and b. The dose of the two fractions was scaled down to 
10 mg/kg and 5 mg/kg in the assay. Interestingly, the antineoplastic effect of 
PU60b still exists and even stronger than that of PU60. PU60b showed the highest 
tumor inhibition ratio (89%) at a dose of 5 mg/kg (Figure 3.14 and Figure 3.15) but 
the tumor inhibition ratio declined when the concentration of PU60b was doubled. 
The antineoplastic effect of PU60a was much weaker than that of PU60b. The 
highest tumor inhibition ratio ofPU60a was 48 % (5 mg/kg) and it further decreased 
to 11 % when the concentration of PU60a was doubled (Figure 3.14). No complete 
tumor regression was recorded in the whole assay. 
3.4.2 MCF-7 tumor inoculation model using athymic nude mice 
3.4.2.1 In vivo antineoplastic effect of PU60b 
Because the most potent dose ofPU60b in S-180 tumor bearing BALB/c mice was 5 
mg/kg, another set of experiment was performed by using athymic nude mice which 
were inoculated with MCF-7 tumors at the back before the treatment (Figure 3.17). 
Two doses of PU60b，10 mg/kg and 5 mg/kg, were respectively administered into the 
mice. The results were shown in Table 3.19 and Figure 3.18. The antineoplastic 
effect of PU60b was greatly lower in the athymic nude mice when compared with 
that on S-180 tumor bearing BALB/c mice. The MCF-7 tumor on athymic nude 
mice was reduced in size by 18 % at a dose of 5 mg/kg and 13 % at a dose of 10 
mg/kg. Two sexes of mice were no mortality, no tumor regression and decrease in 
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body weight in the process of the experiments (Table 3.20)，which was different from 
the response in S-180 tumor bearing mice. 
« 
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Table 3.18 The effects of PU60a and PU60b on S-180 tumor bearing BALB/c mice 
Complete Average Tumor *^umor 
Treatments Mortality Tumor volume ( i W ) 土 inhibition 
Regression S.E.M. ratio (%) 
a C o n t r o l ^ 1/8 0/8 151.14 土 38.01 0 
PU60a 5mg/kg 0/6 0/6 78.79 ±22.62 48 
lOmg/kg 1/6 0/6 134.83 ±19.35 11 
b C o n t r o l P B S 3/8 0/8 350.00 ± 67.27 0 
PU60b 5mg/kg 0/6 0/6 38.86 土 9.01 89** 
lOmg/kg 1/6 0/6 66.81 ± 14.02 81** 
“The item expressed the results of control group for PU60a treatment assay. 
The item expressed the results of control group for PU60b treatment assay. 
c The tumors were excised and measured with a caliper 10 days after 10-day treatment and the 
average tumor volume was expressed in the unit (mrn) 士 S.E.M. 丄 Tumor inhibition ratio (%) = (average tumor volume of treatment group - that of control 
group)/average tumor volume of control group X100% 
120 � • PU60a 
丨 PU6Qb 
S 100 -
j 80 - • • 
60 -
40 -
• • • * * 
” - • I I • 一 
PBS 5 10 
Concentration (mg/kg) 
Figure 3.14 The effects of polysaccharide fractions PU60a and PU60b in different 
concentrations on S-180 solid tumor in vivo. 
PU60a and PU60b at doses of 10 mg/kg and 5 mg/kg were daily injected intraperitoneally into 
the tumor bearing BALB/c mice for 10 consecutive days and PBS was used as control 
Antineoplastic effects on S-180 solid tumor in mice were expressed as percentage of control level 
(Average tumor volume of treatment gwup/Avefcige Tumor volume of control x 100%). 
Statistically significant values were respectively indicated with * and **forp <0.05 andp <0.01. 
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Figure 3.15 S-180 solid tumors excised from BALB/c mice under treatment of 
PU60b at doses of 10/mg/kg and 5 mg/kg. 
PBS was used to treat the control group. 
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Table 3.19 The effects of polysaccharide fractions PU60b in different 
concentrations on MCF-7 tumor bearing athymic nude mice. 
Complete ° Average Tumor ''Tumor 
Treatments Mortality Tumor volume (mm�）土 inhibition 
Regression S.E.M. ratio (%) 
a C o n t r o l P B S 0/8 86.25 土 8.66 0 
bpU60b 5 mg/kg 0/6 0/6 70.42 ±9.88 18 
10 mg/kg 0/6 0/6 74.83 士 12.50 13 
a&b The items expressed the control and treatment groups involving both male and female 
athymic mice where equal number of male and female mice were used in each group, 
c The tumors were excised and measured with a caliper 10 days after 10-day treatment and 
the average tumor volume was expressed in the unit (mm�)± S.E.M. 
“Tumor inhibition ratio (%) = (average tumor volume of treatment group - that of control 
group)/average tumor volume of control group x 100%. 
120 -
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0 ‘ ‘ 
0 5 10 Concentration (mg/kg) 
Figure 3.16 The effects of PU60b in different concentrations on MCF-7 tumor 
bearing athymic nude mice. 
PU60b at doses of 10 mg/kg and 5 mg/kg were daily injected intraperitoneally into the tumor 
bearing athymic mice for 10 consecutive days and PBS was used as control 
Antineoplastic effects on MCF-7 solid tumor on mice were expressed as percentage of control 
level (Average tumor volume of treatment group/Average Tumor volume of control x 100%). 
Statistically significant values were respectively indicated with * and **for p <0.05 and p <0.01. 
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Table 3.20 The effects of PU60b on body weight of S-180 tumor bearing 
BALB/c mice and MCF-7 tumor bearing athymic mice. 
a Average Body Weight (g) 士 S .D. "Percentage 
Treatments ^ ^ ~ ： change in 
Initial Final Body weight 
(0/0) 
S-180 tumor bearing BALB/c mice  
Control PBS 24.36 ± 0.94 25.14 ±1.10 +3.2 
PU60b 5 mg/kg 25.04 ± 1.64 25.92 士 1.01 +3.5 
10 mg/kg 24.61 ±0.80 25.01 土0.83 +1.6 
CMCF-7 tumor bearing athymic mice  
Control PBS 21.00 ±2.26 20.20 土 2.17 — 0.8 
PU60b 5 mg/kg 19.85 ± 1.90 19.42 土 1.98 -0.4 
10 mg/kg 19.68 土 1.54 19.05 ±1.59 — 0.6 
PU60b at doses of 10 mg/kg and 5 mg/kg were daily injected (Up.) into the 
tumor bearing mice for 10 consecutive days and PBS was used as control. 
a The average tumor weight was expressed in the unit (g) 士 S�D. The initial 
body weight of mice was measured after tumor development verification (i.e. 
the first day of sample injection) and the final body weight was measured 
after the enucleation of the tumor from the mice. 
b Percentage change in body weight = (average final body weight - average 
initial body weight)/ average initial body weight x 100 %. 
c All groups of MCF'7 tumor bearing athymic nude mice involved both male 
andfemale mice with equal number of mice. 
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Figure 3.17 The process of in vivo assay with MCF-7 tumor-inoculating model. 
Tumor verification with (a) naked eyes and (b) by hand; (c) Intraperitoneal injection and (d) 
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Figure 3.18 Comparison of MCF-7 tumor size of the athymic nude mice with the 
treatment of PU60b at doses of 5 mg/kg and 10 mg/kg. 
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3.4.3 Identification of cytokines in the serum from healthy BALB/c mice using 
mouse cytokine array system 
Identification of cytokines in the serum from the healthy BALB/c mice which 
received 10-day consecutive treatment with a dose of 10 mg/kg PU60b was 
performed using a mouse cytokine array system (Ray Biotech). Thirty two mouse 
cytokine antibodies were coated on the membrane of the array system in a sequence 
as shown on Table 3.21. The images of the mouse cytokine array membranes 
probed separately with the sera from the control and treatment groups of mice were 
displayed on Figure 3.20. Comparing the relative expression levels between the 
two images of membranes, the serum from the control group of mice contained 21 
types of cytokines out of the 32 cytokines while that from the treatment group 
contained 15 types. There were 15 cytokines that both sera contained. Among the 
expressed cytokines, the expression levels of KC，TIMP-1 and MIP-2 were 
remarkably higher than the others. Cytokines that only existed in the control group 
serum were IL-6，Eotaxin, GCSF, Leptin, Tpo and VEGF (Figure 3.20). 






































































































































































































































































































































































Figure 3.19 The images of the mouse cytokine array membranes on films were 
showed in the figures (a) Treatment group and (b) control group. 
The images referring to the treatment group and control group in the 
alternative style were respectively present as (c) and (d). Circle X encloses 
the spots of MIP-2; circle Y encloses the spots of KC and circle Z encloses the 
spots of TIMP-1. 
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3.4.4 Effect of PU60b on TNF-a generation in healthy BALB/c mice studied with 
ELISA 
TNF-a level in the serum of mice was evaluated with the aid of ELISA. In the 
present study, the mice in the experiment were first administered with PU60b at 
doses of 10 mg/kg and 5 mg/kg for 10 consecutive days. After that, the blood of 
mice was respectively collected on Day 0 and Day 10 of the observation period. 
Half of the control and treatment groups were stimulated by LPS one hour before 
blood collection while the rest of the groups were injected with PBS instead. The 
results were shown in the Figure 3.21. Obviously, the serum levels of TNF-a of 
LSP-primed mice were much higher than those of mice without LPS stimulation. 
The amount of TNF-a generated by LPS-primed mice on Day 10 was much larger 
than that on Day 0; the big difference was significantly obvious especially in those 
from the PU60b treatment groups. Mice injected with 10 mg/kg of PU60b might 
generate TNF-a on Day 10 triple in amounts of TNF-a on Day 0 while there was no 
marked increase as shown in the control group. 
3.4.5 Effect of PU60b on TNF-a generation in S-180 tumor bearing mice studied 
with ELISA 
This assay was done in the same manner as the above-mentioned experiment, except 
the animal model. S-180 tumor bearing mice were used instead. Similarly, the 
serum levels of TNF-a of LPS-primed mice were much higher than those of mice 
without LPS stimulation. However, the level of TNF-a of the control elevated as 
much as those of the treatment groups after LPS stimulation. Such a response was 
not the same in the healthy mice. 
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Figure 3.21 The effect of PU60b on serum level of TNF-a in healthy BALB/c mice. 
Level of TNF-a in the serum collected from the healthy BALB/c mice of 
the control and treatment groups with or without LPS stimulation was 
determined by ELISA using recombinant TNF-a as a standard. 
The blood of mice was collected on Day 0 of the observation period 
(The last day of i.p. injection) and Day 10 of observation period (The 
last day of observation) respectively. 
The results are expressed as mean (pg/ml) 士 S.D. (n=4). 
The Student 's t-test was applied. The data were defined as significant 
and very significant difference from the control group if p < 0.05 (*) 
andp <0.01〔**义 
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Figure 3.22 The effect of PU60b on serum level of TNF-a in S-180 tumor 
bearing BALB/c mice 
Level of TNF-a in the serum collected from the tumor bearing mice of 
the control and treatment groups with or without LPS stimulation was 
determined by ELISA using recombinant TNF-a as a standard. 
The blood of mice was collected on Day 10 of the observation period. 
The results are expressed as mean (pg/ml) 土 S.D. (n=4). 
The Student 's t-test was applied. The data were defined as significant 
and very significant difference from the control group if p < 0.05 (*) 
andp <0.01 (*V-





4.1 Extraction and Isolation of polysaccharide fractions 
Polyporus umbellatus sclerotium, a mass of hyphae compacted underground into rigid 
structures for survival in adverse conditions, was a target source of bioactive 
polysaccharides in the present study. To conserve the intact structure of 
polysaccharides extracted from the sclerotia, only hot water and cold alkali were used 
as solvents of extraction. However, the yields of hot-water extract (PUw) and 
cold-alkali extract (PUAL) were low (25.3% and 34.2%). Comparatively, the yield of 
cold-alkali extract ofPleuwtus tuber-regium was almost doubly higher (60 %) (Deng, 
2000). It may be due to the additional step done in the extraction process that the 
powered sclerotia of Pleurotus tuber-regium were pre-treated with 80 % ethanol three 
times so that small molecular weight substances were removed and the tissues of 
sclerotium were soften, which allow the removal of alkaline soluble polysaccharides 




Water-soluble crude polysaccharides were isolated from hot-water extract PUw by 
ethanol precipitation after pre-treatment with 60 % and 80 % ethanol. It was a 
predictable result that the yield ofPUSO (1.14 %) was higher than that of 60 % (0.48 
%). The higher concentration of ethanol could precipitate almost all water-soluble 
polysaccharides in PUw while PU60 only precipitated certain portion of 
polysaccharides with relatively larger size. Because of the more potent bioactivity of 
fraction PU60 in the preliminary in vivo assay, PU80 was screened out and the work of 
polysaccharide isolation mainly focused on PU60. 
PU60 was further separated into two main fractions (PU60a and PU60b) after elution 
on the DEAE cellulose column. PU60b was considered to be a major polysaccharide 
constituent for PUw (Figure 3.1). Fraction PU60a was regarded as neutral 
polysaccharides as they eluted with distilled water and no acidic sugar was detected in 
this fraction. Based on the ionic charge, polysaccharides eluted with sodium chloride 
solution from anion exchange chromatography are regarded as acidic polysaccharides. 
This was in agreement with the results from the sugar composition analysis for PU60b 
which was eluted with 0.15 M sodium chloride solution as galacturonic acid was 
detected, which indicated that a large proportion of PU60 belongs acidic 
polysaccharides. 
4.2 Chemical characterization of PUw fractions 
PU80 contained the most abundant protein content (w/w) (15.9 %) among all fractions 
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of PUw and PU60 contained proteins (12.6 %) slightly less than that of PU80. 
Surprisingly, the protein contents of PU60a and b which derived from PU60 were 
dramatically lower than that of PU60，which might be due to the fact that protein 
molecules were trapped in the DEAE-cellulose column. PU80 and PU60 shared 
some similarities in terms of types of monosaccharide compositions. Both fractions 
were rich in D-glucose with trace amounts of D-mannose, galacturonic acid, 
D-arabinose and D-galactose in decreasing order. Little difference in xylose and 
glucosamine contents between them was observed. This outcome indicated that the 
fractions PU60 and PU80 most likely contained same types of polysaccharide(s). 
However, the sugar composition of PU60 and PU80 was inconsistent with that in the 
polysaccharide-component analysis by Zhu (1988). Polysaccharides extracted from 
fermented Polyporus umbellatus contained mainly D-mannose, D-galactose and 
D-glucose at the ratio 20:4:1. The difference between the wild strain and the cultivated 
Polyporus umbellatus in monosaccharide composition implies that cultivation 
environments may affect the sugar compositions of the mushroom. On the other hand, 
PU60a and PU60b also contained D-glucose with trace amounts of mannose, 
glucosamine and xylose, rhamnose, galactose together with arabinose in decreasing 
order. Significant difference in contents of glucose and galacturonic acid between 
PU60a and PU60b was found. PU60b contained D-glucose (90.4 %) much more than 
that of PU60a (32.2 %)，which was inconsistent with the results of phenol-sulfuric acid 
assay. It was probably due to the strong hydrophilic ability of PU60a. Water in air 
was absorbed in the dried PU60a during the process of hydrolysis and then diluting the 
sugar composition of this fraction. 
According to Figure 3.2，the hot-water crude extract PUw had no characteristic 
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absorption shown in the infrared spectra. This is probably due to existence of 
impurities and low concentration of polysaccharides in the crude extract, thus 
interfering with the measurement of resonance of functional bonding in the crude 
extract. By contrast, PU60 and PU60a exhibited sharp IR absorption at 890 cm\ 
indicating that the major glucosidic bond of these polysaccharide fractions was the 
P-form and hence they were identified as p-glucans with heteroglycan chains. 
As illustrated in the HPLC chromatograms of PUw fractions (Figure 3.4 and Figure 
3.5), PU60 and PU60b were present as asymmetric peaks, indicating that both 
fractions were probably heterogenous polysaccharides with various molecular weights 
ranged from 19.7 to 607.0 kDa. 93 % of PU60 and 90.4 % of PU60b were eluted 
using HPLC between retention time 17 and 23 minute. PU60a was a relatively 
homogenous polysaccharide showing in Figure 3.4 in the form of a small symmetric 
peak with 20.3 kDa in size. 
4.3 In vitro anti-proliferative effect of PU fractions 
There were not many successful cases of solely use of mushroom polysaccharides 
reported for studying in vitro antitumor effects on cancer cell lines as a result of the 
fact that polysaccharides from mushrooms do not attack cancer cells directly, but 
rather produce their antitumor effects by activating different immune responses in the 
host (Wasser, 2002). Instead, concurrent use of mushroom polysaccharides with 
antibodies like IgG or cytokines like TNF-a, INF-y and IL-2 in vitro were 
comparatively more common in recent research. In the present study, in vitro assay 
were used as preliminary estimation on anti-proliferative potentials of PU fractions as 
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usual. Research on in vitro anti-proliferative effects of Polyporus umbellatus 
polysaccharides by Yadomae (1979) demonstrated that the purified hot-water extracts 
ofPolyporus umbellatus demonstrated a mitogenic effect in vitro. Mitogenic effect is 
an effect in stimulating cellular multiplication (Hobbs, 1995). On the whole, 
mitogenic effect of hot-water crude extract (PUw) on cancer cells was also observed in 
the present study with high viability. Cell density of cell lines S-180, HL-60, HepG2 
and Colon 201 was increased up to 35.1% under the 72-hour treatment. A trend of 
dose-dependent increase in cell density was found in HL-60 cells. 
Interestingly, the mitogenic effect of fraction PUw on the above cancer cell lines did 
not consistently exhibit under the treatment of another three fractions PUAL, PU80 and 
PU60. The highest increase percentage of cell density was 62.2 % (Colon 201 cells 
treated with P U A L at a dose of 200 ng/ml). By contrast, proliferation of cell lines 
S-180and MCF-7 was inhibited when treated with the three fractions (Figure 3.6 and 
Figure 3.8). Despite limited cell proliferation inhibition, anti-proliferative effect of 
PU60 was the highest among the three fractions. Such a contradictory outcome was 
also found in mushroom heteropolysaccharides wc-PCMO, wb-PCMl and ab-PCMl 
isolated from Poria cocos (Jin, 2003). These fractions of Poria cocos enhanced cell 
proliferation of HepG2 cells but showed inhibition on HL-60 cell proliferation. The 
reason of this phenomenon is still unknown. Perhaps various types of cells possess 
different extent of sensitivity to the polysaccharides and present distinct cell surface 
receptors for generating cell signaling. To further identify the ability of direct 
cytotoxicity of PU fractions towards cell lines, normal kidney cells (Vero) was used as 
the control. Vero cells did not demonstrate considerable change in cell density 
(Figure 3.10) and viability (data now shown) after 72-hour treatment of the PUw, PUAL 
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and PU60, indicating that the various PU fractions had no direct cytotoxicity on 
normal cells and they were safe to use in the animal models. Only PU80 exhibited 
mitogenic effect on Vero cells and the most potent dose was 200)ig/ml. 
Similar to lentinan from Lentinus edodes (Chihara, 1992) and GLPP, a purified 
polysaccharide isolated from Ganoderma lucidum (Cao, 2004)，PU fractions failed to 
attack cancer cell lines directly, which revealed that Polyporus umbellatus 
polysaccharides were not ideal for use as an antiproliferative agent. Thus animal 
models were set up as the next step to determine in vivo antitumor activity of 
polysaccharide fractions in this present study. 
4.4 In vivo antineoplastic assay of PU fractions 
4.4.1 S-180 solid tumor model using BALB/c mice 
In vivo preliminary antitumor tests were performed to estimate which crude extract, 
PUw or PUAL. was worthy of fiirther fractionation. According to the review of Ooi 
and Liu (2000)，the preliminary determination of antineoplastic activity relied on 
several essential factors such as bioassay system, strain of mice, type of tumor and 
route of drug administration (Zhang, 2002). Ascitic Sarcoma 180 was selected so that 
an allogeneic tumor could be developed while BALB/c mice was chosen because this 
strain of mice is so commonly used in in vivo antitumor assay of mushrooms and hence 
facilitated comparison among them. In view of low yield and high solubility of the 
PU fractions, intraperitoneal injection was applied as less amount of sample was used 
in each dose when compared with the dose for oral administration and the soluble 
fractions might be directly absorbed into blood stream by diffusion via intraperitoneal 




Hot-water and cold-alkali crude extracts at a dose of 100 mg/kg were administered 
into S-180 tumor bearing mice in the 20-clay preliminary study. Both crude extracts 
could effectively inhibit the tumor growth at the dosage (Figure 3.12). Fraction PUw 
retarded tumor growth by 76 %，which was slightly higher than P U A L did (68 %). 
About 14 % tumor bearing mice of PUw treatment group showed complete tumor 
regression while PUAL-treated mice showed no complete tumor regression. In the 
history of mushroom research, hot-water extracts from edible mushrooms belonging 
family Polyporaceae also showed remarkable antineoplastic activity on S-180 solid 
tumor. Ganoderma tsugae, Coriolus versicolor and Favolus alveolarius are good 
examples among them (Mizuno, 1995). Their tumor inhibition ratios are up to 77 %. 
Another mushroom in the same family, Trametes dickinsii, could exhibit tumor 
inhibition even by 80 % (Mizuno, 1995). Based on the distinguishable results 
between the two groups in addition to a fact that higher mortality was observed in the 
record of PUAL-treated groups (42.8 %)，fraction PUAL was neglected and the focus 
was placed on the PUw fraction in the following assay. 
The following assay was done in order to determine the range of effective dose of 
PUw. As a dose of 100 mg/kg PUw had shown to exhibit such a notable tumor 
inhibition ratio, the dosage of the fraction was scaled down to 50 mg/kg, 25 mg/kg 
and 12.5 mg/kg. The result showed that the lower doses the treated mice took, the 
more potent the antineoplastic effect of PUw exhibited. Nevertheless, the most 
potent dose was found to be 100 mg/kg on the whole which significantly exhibited 
79 % inhibition on tumor growth while a dose of 12.5 mg/kg might inhibit tumor 
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growth by 69 % only. Because of this abnormal phenomenon, the same range of 
dose with little amendment was repeated in the assay with fraction PU60 and PU80. 
The similar trend was found in fraction PU80 (Table 3.16): the ratio of tumor 
inhibition was high at a dose of 100 mg/kg and then decreased to 59 % at a dose of 
50 mg/kg and rebounded to 76 % when the dose was 5-fold diluted. On the other 
hand, the tumor inhibition ratios at 75 to 80 % of fraction PU60 were quite similar at 
doses ranged from 10 mg/kg, 50 mg/kg and 100 mg/kg. As discussed in Section 4.2， 
fractions PU60 and PU80 most likely shared the same types of polysaccharide(s); the 
different outcome between the two assays of similar polysaccharide fractions 
reflected a possibility that PU60 fraction contained sugar compositions with more 
antineoplastic properties. Relatively, PU80 included extra sugar components that 
lowered the concentration of the effective monosaccharides at the fixed dose and its 
antineoplastic nature was distracted. 
Change in body weight was measured in the duration of experiment. All mice in 
treatment groups did not reduce their body weight in the end of experiment. The 
percentage of body weight gain of PU60-treated mice was greater than those of the 
corresponding control group and PU80-treated mice. It basically indicated that they 
had no effect on body weight change of cancer objects as chemotherapeutic drugs do. 
After screening out the PU80 fraction, PU60 was further fractionated with the aid of 
DEAE column, producing PU60a and b. As the tumor inhibition ratios of fraction 
PU60 showed steadily around 75 to 80 % at the doses ranged from 10 mg/kg, 50 
mg/kg and 100 mg/kg, the doses of the two fractions used was fiirther scaled down to 
10 mg/kg and 5 mg/kg in the assay. An inspiring outcome was that the 
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antineoplastic effect of PU60b was still prominent and was stronger than that of 
PU60. PU60b showed the highest tumor inhibition ratio (89%) at a dose of 5 mg/kg 
but the tumor inhibition effect slightly declined when the concentration of PU60b 
was doubled. On the other hand, the antineoplastic effect of PU60a was much 
lower than that ofPU60b. The highest tumor inhibition ratio of PU60a was 48 % (5 
mg/kg) and it further decreased to 11 % when the concentration of PU60a was 
doubled. Obviously, acidic polysaccharides of Polyporus umbellatus (PU60b) 
exerted profound inhibition effect on tumor growth much better than the neutral 
polysaccharide (PU60a) did. This evidence was also found in the mushroom 
Tricholoma sp. (Liu, 1995). Acidic polysaccharide fraction A-2 of Tricholoma sp. 
(strain STC20-T1) showed much potent antineoplastic effect on both BALB/c and 
ICR mice when compared with its neutral polysaccharide fraction A-1. Despite that, 
there are differences in monosaccharide composition and protein content between the 
two effective acidic polysaccharides. PU60b contained mainly D-glucose (90.4%) 
with little protein (4.8 %) while A-2 included mainly galactose (49.3 %) with protein 
(30.1 %). 
4.4.2 MCF-7 tumor in vivo model using athymic nude mice 
Nude mice can be used to not only answer many questions in immunology, but support 
growth of many types of cells and tumors especially those of mouse origin due to 
their immunodeficiency. The main characteristics of an athymic nude mouse are the 
absence of the thymus and absence of hair due to impaired keratinization resulting in 
breakage of the hairs within the follicles (Corbett, 2002). There is a general agreement 
that the hairless condition and the failure of thymus development are due to some basic 
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defect in the embryonic ectoderm, and the first detectable abnormalities in the 
development of the nude thymus are in the ectodermal component occurring during 
the formation of a cervical vesicle on day 11 of embryonic life. The absence of 
functioning T cells prevents nude mice from rejecting not only allografts, but they 
cannot even reject xenografts (Clarke, 2002); that is, grafts of tissue from another 
species. T cells are white blood cells produced by the thymus gland and sent out to 
patrol the body in search of viruses and other invaders. T cells can differentiate into a 
surface marker called CD4+ T helper cells that regulate the activity of 
antibody-producing B cells and of other T cells such as CD8+ cytotoxic T cells which 
is responsible for cell-mediated immune responses and killing of virus-infected or 
malignant cells (Goldsby, 2002). 
PU60 mediated a significant tumor inhibition of S-180 solid tumor in BALB/c model. 
Its in vivo antineoplastic effect might be due to direct toxicity, tumor-sensitive toxic 
metabolic derivatives such as NO and/or immunostimulatory properties of PU60b. 
The possibility of direct toxicity of PU60b was excluded because all fractions of PUw 
failed to show antiproliferative effect on cancer cells in this study. Other than that, 
fraction PU60b was able to inhibit tumor growth effectively in BALB/c mice but 
mediated no tumor regression in athymic mice, which implied that the fraction were 
not metabolized to tumor-sensitive toxic substances. Hence, fraction PU60b most 
likely mediates tumor regression in vivo by the activation of host immune effector 
mechanisms. 
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4.5 Estimation of Immunomodulatory properties of PU60b 
4.5.1 Identification of cytokines in serum from healthy BALB/c mice 
The ability of a tumor to escape from immunological control may depend on a balance 
between the effectiveness of the immune system and a variety of factors promoting 
escape of tumor cells from destruction by effector components of the immune system. 
Mushroom polysaccharides are claimed to modulate the immune system and 
potentially exert antitumor effects (Borchers, 1999). With the aid of RayBio™ 
Mouse Cytokine Array, outline of serum cytokine production in PU60b-treated 
healthy mice was revealed on the membrane. R a y B i o ™ Mouse Cytokine Array is a 
cytokine protein array system which can be used to rapidly and accurately identify the 
expression profiles of multiple cytokines. In fact, all cell functions, including cell 
differentiation，cell proliferation and cell death together with maintenance of health 
status and development of disease are regulated by gene expression and signaling 
pathways. New techniques such as cDNA microarrays facilitate people to analyze the 
global gene expression. However, almost all cell functions are regulated by proteins, 
which is not enough to be studied only by DNA and RNA solely. Gygi (1999) stated 
that a disparity between the relative expression levels of mRNA and their 
corresponding proteins. Thus, it is indispensable to analyze the protein profile. 
Currently, two-dimensional polyacrylamide SDS PAGE and mass spectrometry are the 
mainstream approach to analyzing multiple protein expression levels (Anderson, 2000; 
Legrain, 2000). Nevertheless, the requirement of sophisticated devices and the lack 
of quantitative measurements greatly limit their broad application. Considering that 
the cytokine protein array system can perform simultaneous detection of 32 types of 
cytokines, it was suitable for estimating the immunomodulatory properties ofPU60b. 
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Surprisingly, cytokines IL-6, Eotaxin, GCSF, Leptin, Tpo and VEGF existed only in 
the serum of control group. It was probably that PU60b down-regulated the 
expression of these kinds of cytokines. Despite that, Yang et al. (2004) demonstrated 
that the immunosuppression properties of tumor cell suspension S-180 such as 
declining of splenocyte proliferation, IL-2 production and natural killer cells activity 
were counteracted with polysaccharide extracted from P. umbellatus (PUPS) as a 
result of the down-regulating the synthesis and/or secretion of immunosuppressive 
substance by SI 80 cells. There were 15 types of cytokines commonly expressed in 
both sera. Among the expressed cytokines, the expression levels of KC, TIMP-1 and 
MIP-2 were higher than the others. Among them, tissue inhibitor of matrix 
metalloproteinases-1 (TIMP-1) and macrophage inflammatory protein-2 (MIP-2) are 
involved in antitumor activity (Sun, 2000; Brand, 2002; Ikenaka, 2003). 
Intratumoral injection of AdCMVmCD40L, an adenoviral vector, causes antitumor 
effect in the animal model associated with the intratumoral production of IL-12 and 
IFN-y and with an increased intratumoral expression of chemokines such as MIP- la , 
MIP-lp, MIP-2 and eotaxin (Sun, 2000). The induction of the antitumor agent leads 
a powerful cascade of chemokines and cytokines in the tumor mass and stimulate an 
efficient antitumor immunity. Matrix metalloproteinases (MMPs) are crucial 
enzymes involved in the degradation of the extracellular matrix for the invasive 
behavior of primary tumors and their metastases (Rigg, 2001; Brand，2002). TIMPs 
exert an anti-invasive effect by blocking MMP activity (Miyata et al.’ 2004). It has 
been shown that overexpression of TIMPs in tumors of various origins leads to 
reduced tumor growth and formation of metastases (Brand, 2002). 
- 1 0 7 -
Chapter 4 
Discussion 
In the present study, both healthy and tumor bearing mice were used to investigate 
whether the polysaccharides from Polyporus umbellatus sclerotium were able to 
elevate TNF-a generation by using ELISA. The level of TNF-a is a parameter to 
evaluate the immunostimulating ability of polysaccharides on peritoneal macrophage 
proliferation as this cytokine, mainly produced by macrophages (Inoue, 2002), is one 
of the commonly used in tumor immunotherapy (Kuninaka et al., 2000; Terlikowski, 
2002). Obviously, the serum level of TNF-a of LPS-primed healthy mice was 
much higher than that of mice without LPS stimulation. The amount of TNF-a 
generated by LPS-primed mice on Day 10 was much larger than that on Day 0; the 
big difference was significant especially in those from the PU60b treatment groups. 
PU60b-treated mice with LPS stimulation on Day 10 might generate a 3-fold 
increase in the production of TNF-a when compared with control group and that on 
Day 0. The results reflected that fraction PU60b exhibited immunostimulating 
effect which might last long in the host. More of acquired macrophages, T and B 
lymphocytes were produced and circulated in the blood. When the mice stimulated 
with LPS, the acquired immune cells secreted cytokines like TNF-a to protect the 
host. Similar outcome was also found in D-fraction (from Grifola fwndosa) treated 
mice (Inoue, 2002). D-fraction-treated mice exhibited a 2.5-fold increase in TNF-a 
production compared to the control. 
When repeating the same assay with the sera collected from tumor-bearing mice, 
notable different in the level of TNF-a was also observed. However, an odd outcome 
was found in the control group. Perhaps, tumor cells in mice interfered with their 
immunity. In fact, immune system in tumor bearing mice maybe more complicated 
than that of healthy mice. The relationship between tumor cells and host immune 
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In the present study, two mushroom polysaccharide fractions, PU60a and PU60b, have 
been isolated from the sclerotium of Polyporus umbellatus. Both of them were 
identified as P-glucans with heteroglycan chains. Fraction PU60a is regarded as a 
group of homogenous neutral polysaccharides while PU60b is a group of 
heterogenous acidic polysaccharides with various molecular weights ranged from 19.7 
to 607.0 kDa. PU60b exhibited the highest tumor inhibition ratio (89%) at a dose of 
5 mg/kg in the S-180 tumor model using BALB/c mice. However, no remarkable 
proliferation inhibition was found in vitro assay. Hence, the possibility of direct 
cytotoxicity of PU60b on tumor cells was excluded. In the assessment of TNF-a 
production using ELISA, PU60b-treated mice on Day 10 with LPS stimulation could 
generate 3-fold increase in the production of TNF-a when compared with the control 
group and that on Day 0. The result reflected that the immunostimulation of the 
PU60b had a longer lasting effect in the hosts. In the assay of cytokines detected on 
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membranes of mouse cytokine array, intensities of tissue inhibitor of matrix 
metalloproteinases-1 (TIMP-1) and macrophage inflammatory protein-2 (MIP-2) in 
PU60b-treated healthy mice serum were high. These studies could support that 
TIMP-1 and MIP-2 were probably involved in antitumor activity causing the 
production of a powerful cascade of chemokines and cytokines in the tumor mass and 
stimulating an efficient antitumor immunity. 
Based on the conclusions of the experiment, some ftirther investigations are proposed. 
In the present study, the yield of PU60b extracted from the sclerotium was rather low; 
the extraction method can be modified to elevate the yield of the polysaccharide 
fraction by using enzymes such as chitinase that enhance the breakage of fungal cell 
wall to release the p-glucans. Other than that, the potent antineoplastic effects of 
PU60b will be further studied by mainly focusing on the role of TNF-a, TIMP-1 and 
MIP-2 with the aid of transgenic mice models and flow cytometry. 
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Table 3.21 Antibody list on the membrane of RayBio™ Mouse Cytokine Array. 
A B C D E F G H I J K L 
1 p � pn, N«a 6Ckine CTACK Eotaxin GCSF GM-CSF IL-2 IL-3 IL-4 
2 — ^ ^ 6Ckine CTACK Eotaxin GCSF GM-CSF IL-2 IL-3 IL-4 
3 " i i T s i L ^ n i r f e i L U T " IL-12p70 IL-13 IL-17 IFN-y KC Leptin MCP-1 
4 " I T s O O ~ ~ n T i F " IL-12 IL-12p70 IL-13 IL-17 IFN-y KC Leptin MCP-1 
5 Mrp-C MTP-lr. M i p l ^ j ^ - s p RANTES SCF sTNFri TARC TIMP-1 TNF-a Tpo VEGF 
6 MCP.S MIP.I" M l ^ MIP-3B "RANTES SCF sTNFri TARC TIMP-1 TNF-g Tpo VEGF 
7 B l a n k ~ ~ R w i k " " ^ ! ^ Blank Blank Blank Blank Blank Blank Blank Blank Pos 
8 Blank Blank Blank Blank Blank Blank Blank Blank Blank Blank Pos 
(Ray Biotech, 2003) 
tNote: Pos - positive control; Neg - negative control. 




3 r Distilled water O t o l M N a C l  
2 . 5 f ‘ ‘ 
I I PU60b 
I \ 
I 1 . 5 - \ 
0 L - - ‘ 
0 2 0 4 0 60 80 100 120 
Number of Tubes (6 ml/tube) 
Figure 3.1 Anion exchange chromatography of PU60 on a DEAE-cellulose column. 
SO mg of PU60 was applied to a 2.5 x 30 cm DEAE-cellulose anion exchange column. The flow rale was 30 ml/h and the 
fracLation was collected at 6 ml/tube. The column was eluted stepwise with distilkd^ater to obtam the unbound component 
(PU60a) and with a salt gradient o/NaCl (0 to 1 M) to obtain the retained component (PU60b). 
The presence of carbohydrate was determined by the phenol-sulphuric assay at 490 nm. 
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